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Abstract 
 
 
Today’s biology relies heavily on technological advances made during the 
last 30 years. At the same time, the way of analyzing a biological question 
changed and nowadays we aim at understanding globally the system un-
der study. DNA microarray technology allows events to be measured at a 
genome-wide scale leveraging the need for an educated guess approach. 
Global gene expression profiling is the most frequent application of DNA 
microarrays and is used to study different cell types in diverse experi-
mental setups. 
 
In this work, I have (1) subjected DNA microarray data to different min-
ing approaches for the identification of gene signatures in stem cell differ-
entiation and reprogramming, and (2) developed a workflow for semantic 
annotation of microarray data from public repositories. 
 
Dendritic cells (DC) were treated with TGF-β and subjected to global 
gene expression profiling. DC are derived from hematopoietic stem cells. 
They initiate immunity and induce antigen-specific tolerance, making 
these cells major candidates for cell-based therapies. Our study revealed 
key regulatory factors in the answer of DC to TGF-β1. 
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Chromatin structure determines gene expression and thereby cells iden-
tity and cells fate. Drugs that alter DNA methylation and histone acety-
lation modify the chromatin structure and were found to broaden the 
developmental potential of neural stem cells (NSC). Microarray analysis 
revealed the induction of pluripotency-associated genes by chromatin 
modifying drug treatment, that are suggested to account for the altered 
potential of these cells. 
 
Pluripotent stem cells, including embryonic stem cells (ESC), are able to 
generate all cell types present in the adult body, however the isolation 
and cultivation of such cells raised some ethical and technical concerns. 
For this reason alternative methods have been developed to generate ES-
like cells from somatic cells or adult stem cells. The medical and research 
applications of such reprogrammed cells are extremely promising. Gene 
expression profiling of induced pluripotent stem (iPS) cells, either gener-
ated using two or four reprogramming transcription factors (Oct4 and 
Klf4 or Oct4, Klf4, Sox2 and c-Myc), revealed a gene expression signature 
similar to ESC. 
 
The gene array technology underlying such studies generates an enor-
mous amount of data that is usually stored in database made available 
to the community. However the descriptions available for the experiments 
are made in free text. Thus, retrieving and associating microarray ex-
periments is subjected to a comprehensible labeling from the submitter. 
Linking different sources of data requires description made in a vocabu-
lary on which everybody agrees such as biomedical ontologies. An ontol-
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ogy organizes knowledge of a particular domain in a define network of 
relationships. 
In this work I developed a workflow for semantic annotation of microar-
ray public repositories. Gene Expression Omnibus (GEO), the biggest 
public repository of microarray data, was subjected to the workflow and 
annotated using different ontologies. The method relies on text mining, 
outlier detection and an algorithm for label propagation of labeled ob-
jects to unlabeled objects, in order to increase the labeling coverage. The 
algorithm adapts the label propagation to the specificity of the biological 
sample type measured. 
 
Integrative bioinformatics studies that merge different data types to dis-
cover new relationships between diseases, phenotypes and gene expression 
profiles will benefit from standardized annotation of the experiments. 
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Zusammenfassung 
 
 
Die heutigen biologischen Erkenntnisse stützen sich vor allem auf die 
technologischen Fortschritte der lezten 30 Jahre. Zur selben Zeit hat sich 
die Art und Weise, ein biologisches Problem anzugehen, verändert, in 
dem man auf ein globales Verständnis der zu untersuchenden Systeme 
hinarbeitet. Die Technik der DNA microarrays erlaubt es, Fragestell-
ungen auf Genomebene zu beantworten. Die Erstellung eines globalen 
Genexpressionsprofils ist die häufigste Anwendung von DNA microar-
rays. In dieser Arbeit wurde diese Methode angewandt, um ein besseres, 
globales Verständnis für die Differenzierung verschiedener Zelltypen unter 
unterschiedlichsten experimentellen Bedingungen zu erforschen. 
 
In dieser Arbeit habe ich (1) DNA microarray Daten mit Hilfe unter-
schiedlicher Methoden bearbeitet, um neue Gensignaturen in Stammzell-
differenzierung und „Reprogramming“ zu identifizieren und (2) einen Ar-
beitsablauf für semantische Annotation von DNA microarrays aus öffent-
lich zugänglichen Datenbanken entwickelt. 
Dendritische Zellen (DC) wurden mit TGF-β behandelt und einer glo-
balen Genexpressionsanalys zugeführt. DC stammen von hämatopoieti-
schen Stammzellen. Sie initiieren Immunität und induzieren antigen-
spezifische Toleranz in der Körperabwehr, daher sind diese Zellen beson-
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ders für zellbasierende Therapieansätze von Interesse. In dieser Studie 
wurden Schlüsselgene aufgedeckt, die bei der Reaktion der dendritischen 
Zelle auf TGF-β eine Rolle spielen. 
 
Die Chromatinstruktur kann die Genexpression bestimmen und somit 
auch die Zellidentität und das Zellschicksal. Daher können Substanzen, 
die die DNA-Methylierung und die Histonacetylierung beeinflussen, die 
Chromatinstruktur modifizieren, so dass ein erweitertes Entwicklungspo-
tential von zum Beispiel neuralen Stammzellen möglich ist. Microarray 
Analysen offenbarten die Induktion von Pluripotenz und pluripotenz-
assoziierten Genen durch solche Substanzen, und somit eine mögliche 
Erklärung des veränderten Potentials dieser Zellen.  
 
Pluripotente Stammzellen, einschließlich embryonale Stammzellen (ESC), 
sind in der Lage, alle Zelltypen des Körpers zu generieren. Auch wenn die 
Eigenschaften pluripotenter Stammzellen besonders attraktiv für medizi-
nische Zwecke sind, haben die Isolation und Kultivierung solcher Zellen 
ethische und technische Bedenken hervorgerufen. Daher haben sich alter-
native Methoden für die Generierung ES-ähnlicher Zellen von somati-
schen Zellen oder adulten Stammzellen entwickelt. Die medizinische und 
wissenschaftliche Anwendung solcher Zellen ist sehr vielversprechend. 
Genexpressionsprofile von induzierten pluripotenten Stammzellen (iPS 
Zellen), generiert entweder durch zwei oder vier „reprogramming“ 
Transkriptionsfaktoren (Oct4 und Klf4 oder Oct4, Klf4, Sox2 und c-
Myc), zeigen eine genomische Signatur, die den ESC ähnlich ist. 
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Die Anwendung von DNA microarrays für genomweite Studien bringt 
eine enorme Menge an Daten mit sich, die in öffentlichen Datenbanken 
gespeichert ist. Die Beschreibung der Daten erfolgt jedoch in freiem Text. 
Es ist Aufgabe der Forscher, diese Daten mit verständlichen Labeln zu 
beschreiben, um eine Zuordnung von Experimenten und Anfragen darauf 
zu ermöglichen. Das Verknüpfen von verschiedenen Informationsquellen 
benötigt ein einheitliches Vokabular, wie z.B. biomedizinische Ontologien, 
auf das sich alle Beteiligten geeinigt haben. Ontologien organisieren In-
formationen in einem definierten Netzwerk von Relationen. In dieser Ar-
beit wurde ein Arbeitsablauf erstellt, um öffentlich zugängliche microar-
ray Datensätze semantische zu annotieren. Dazu wurden Daten aus Gene 
Expression Omnibus (GEO), der größten öffentlichen Datenbank für 
DNA microarrays, extrahiert und mit Hilfe unterschiedlicher Ontologien 
annotiert. Zur Anwendung kamen dabei „Textmining“, „Outlier Detecti-
on“ und „Label Propagation“ Techniken. Label Propagation überträgt 
dabei Label von bereits annotierten auf noch nicht beschriebene Daten-
sätze, anhand der Ausprägung von Expressionsprofilen, um die Menge an 
korrekt annotierten Datensätzen zu erhöhen.  
 
Integrative Bioinformatik, beschäftigt sich mit einem solchen Zusammen-
bringen von unterschiedlichen Datentypen, um neue Zusammenhänge un-
ter anderem zwischen Krankheiten, deren Ausprägungen und Genexpres-
sionsprofilen aufzudecken, und wird von dieser Art der standardisierten 
Annotierung profitieren. 
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Abbreviations 
AE Array Express 
Aza-C 5-Aza-2’-deoxycytidine 
BLAST Basic local alignment search tool 
c-Myc v-myc myelocytomatosis viral oncogene homolog 
CD Cluster of differentiation 
ChIP Chromatin immunoprecipitation 
DC Dendritic cells 
DNA Deoxyribonucleic acid 
ESC Embryonic stem cell 
Flt3+ESC/HSC Fusion hybrids cell from Flt3+HSC and ESC 
Flt3+HSC Flt3+ progenitor cells 
GCRMA GeneChip robust multi-array analysis 
GEO Gene Expression Omnibus 
GO Gene Ontology 
gPS germline pluripotent stem cells 
HSC Hematopoietic stem cell 
Id2 Inhibitor of differentiation / DNA binding 2 
IL Interleukin 
iPS Induced pluripotent stem cells 
Klf4 Krüppel-like factor 4 
LC Langerhans cells 
MM mis-match 
NSC Neural stem cell 
Oct4 Octamer 4 gene 
PAM Partition around medoid 
PCA Principal component analysis 
pDC Plasmacytoid dendritic cells 
PM Perfect match 
RMA Robust multi-array analysis 
RNA Ribonucleic acid 
SMD Stanford microarray database 
SNPs Single nucleotide polymorphism 
Sox2 SRY (sex determining region Y)-box 2 
TGF-β1 Transforming growth factor type-β1 
TSA Trichostatin A 
wt Wild-type 
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1 Introduction 
 
 
1.1 A Genomic Age 
The genomic area started 30 years ago with the publication of the bacte-
riophage MS2 genomic sequence in 1976 (Fiers et al., 1976). It was the 
first entire genome to be sequenced and assembled. The RNA sequence 
was 3,569 nucleotides long, assembled by hand and a printed version of it 
was given in the published Nature article. While it might look like prehis-
tory to the youngest of us nowadays, it was undoubtedly a huge step 
forward in biology at that time. During the next 14 years the technology 
evolved and high-thoughput sequencing technology such as the whole ge-
nome shotgun (Sanger et al., 1977; Anderson, 1981) paved the way for a 
new genomic area. Only a few complete genomes were sequenced, such as 
the bacteriophage Φ-X174 (Sanger et al., 1977) and the simian virus 40 
(Reddy et al., 1978). In 1988 the idea of a project for sequencing the en-
tire human genome was first proposed by DeLisi (DeLisi, 1988). This 
enormous project officially started in 1990 and represented a worldwide 
scientific effort to produce the base for the research of the 21th century. 
While the human genome project was running, other major genomes 
were released. In 1995, the first complete genome sequence from a free liv-
ing organism, a bacteria named Haemophilus influenzae Rd was pub-
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lished (Fleischmann et al., 1995), followed the next year by the first eu-
karyote, Saccharomyces cerevisiae, released by a European consortium 
of laboratories (Goffeau et al., 1996). At this date, the human genome 
project was officially running since 6 years at the National Human Ge-
nome Research Institute (NHGRI). The competition between the private 
company Celera Genomics and the public consortium was gradually 
reaching its apogee. The public consortium “won” the race by one day, 
publishing the initial sequence and analysis of the human genome on 
February 15 2001 (Lander et al., 2001) before Celera Genomics (Venter 
et al., 2001). This deluge of data raised challenges of data storage and 
analysis early in the discovery process (Staden, 1977; Kelly, 1989). The 
focus on sequencing brought money to this field of research and drove 
new technical innovations (Nyren, 2007; Pettersson et al., 2008). Nowa-
days, commercial solutions read billions of base pairs in a single run and 
bacterial genomes can be sequenced in a few hours. GenBank, the se-
quence database was established in 1982 by the National Institutes of 
Health (NIH) and is hosted at the National Center for Biotechnology In-
formation (NCBI). Its purpose is to store all the genomic sequences pub-
lished and make them available to the research community. Other mirror 
databases appeared later in Europe and Japan (Cochrane et al., 2008; 
Sugawara et al., 2008). 
 
The ultimate goal of the human genome project is to help the field of 
medicine to understand and eventually treat genetic diseases. However, 
some disease susceptibilities are caused by genomic sequence variation 
specific to an individual called single nucleotide polymorphism (SNPs). 
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The human genome project is a consensus sequence representing an “av-
erage” version of the human genome and consequently the next step in 
genome sequencing is the generation of personal genomes 
(www.personalgenomes.org, www.1000genomes.org). In this respect, the 
human genome project can be considered as “first draft”. Today some 
startup companies, such as Complete Genomics 
(www.completegenomicsinc.com), receiving support from renowned scien-
tist, propose to sequence a genome for 5000 dollars. The potential of ob-
taining the full genome sequence of individuals raised several ethical con-
cerns and opens new medical perspectives. First, ethical questions regard-
ing eugenic discrimination based on genomic background. It is possible to 
imagine in a near future having access to health information from a 
blood test. On the other hand having access to patient personal genomic 
information could possibly allow earlier diagnosis and better treatment 
prescriptions. These individual genomes represent also invaluable infor-
mation for biomedical research. 
 
1.2 Bioinformatics 
The term “bioinformatics” appeared lately in the 1980’s as a concept to 
describe a new kind of computer-based biology. The field of application of 
bioinformatics is diverse and multiple approaches exist using different ra-
tios of mathematics, computer science, biology and chemistry. Bioinfor-
matics has its roots entangle with computer technology advance, as it is 
a requirement to manipulate large data sets. Alan M. Turing, who is of-
ten considered as the father of modern computational science, was work-
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ing at the end of his life on mathematical biology. He published his last 
paper on “The chemical basis of morphogenesis” (Turing, 1952). The pa-
per describes a mathematical model of the growing embryo and required 
knowledge in mathematics, biology and chemistry. This interdisciplinary 
approach can be considered as the main characteristic of bioinformatics. 
Some applications of bioinformatics are now considered standard tech-
niques in biology, such as performing in silico sequence alignments with 
tools like BLAST (Altschul et al., 1990) or predicting the secondary 
structure of a amino-acid sequence with HNN (Eddy, 1998). 
 
1.3 DNA Microarray Technologies 
Biomedical research nowadays is marked by the trend of having a global 
understanding of the system studied (Brambrink et al., 2008). Viewing 
the system as a whole to obtain the “big picture” is the de facto approach 
undertaken by all new research projects. High-throughput techniques to 
obtain overviews of the transcriptome, proteome and other “–ome” (see 
Table 1.1) are required for achieving this goal. 
 
The transcriptomic field has been especially flourishing during the past 
decade. The state of the art platforms to measure the transcriptome are 
DNA microarrays. The first arrays, created in the mid 1980’s, were called 
macroarrays. They were fabricated by spotting DNA probes on a nylon 
membrane (Fig. 1.1A) with spot sizes of about 300 microns, which lim-
ited the density of the spots to about 2000 probes. The array is globally  
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call ‘probe’ and the sample to hybridize ‘target’. They were mostly spot-
ted with DNA clones or PCR products, and typically were used with 
radioactively labeled targets. The next generation of arrays were created 
by using pin spotter robots. These are pin-based robotic systems that 
Table 1.1. List of the most common ‘ome’ concepts. 
Genome  The entire DNA sequence of a particular organism. Sometime re-
duced to the entire set of genes. 
Transcriptome The ensemble of transcripts (mRNA) present in one cell at a time 
point t. DNA microarray is the technology to measure in a single 
experiment the relative expression level of a gene. The gene expres-
sion level measure is not quantitative with microarrays and thus a 
control is always required. 
Proteome All the proteins present in one cell or cellular compartment at a 
specified time point. Numerous techniques exist, the most widely 
technique used is immunoprecipitation combined with mass spec-
trometry. 
Metabolome All chemical components (mRNA and protein excluded) present in a 
cell or tissue. Metabolomics uses techniques originating from bio-
chemistry. High throughput methods use mainly mass spectrometry, 
gas or liquid chromatography or nuclear magnetic resonance (NMR) 
for metabolite analysis. 
Epigenome The state of DNA methylation and histone acetylation at a particu-
lar stage of development of a cell. The epigenome state of a cell has 
revealed itself as a major player in the cell developmental fate. The 
epigenome can be divided into methylome and acetylome. 
Diseasome The collection of all diseases. Diseases can be put in relation to each 
other by different –omics techniques or organized in an ontology. 
Phenome The phenome refers to the presence or absence of particular pheno-
types conferred by gene knockout or an environmental influence. 
Envirome The complete set of environmental influences a system (cell or organ-
ism) can receive. Basically all the influences that trigger an observed 
phenotype. 
Interactome The interactome represent all the molecular interaction observed in a 
system independently of time. Interaction partners can be inferred 
from experimental sources such as co-immunoprecipitation or from 
literature mining techniques like co-citation. 
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can dispense an accurate volume of a DNA solution in a spot of about 
150 microns onto the support, usually a microscope glass slide. DNA 
clones, PCR products or pre-synthesized oligonucleotides can be bound 
to the glass surface to create high-density arrays (Fig. 1.1A). By the mid 
1990’s, researchers were already using microarrays to investigate differ-
ences in expression profiles for (i) tissues of different types, (ii) to evalu-
ate bacterial cell lines in different stages of their life cycle, (iii) to investi-
gate which genes were involved in cell division and (iv) to investigate 
drug dose effects. To create a microarray one had to (i) choose the genes 
of interest, (ii) obtained the clone and (iii) amplified it by PCR. The 
PCR products were stored in 96 or 384 well plates and a robot was spot-
ting the solution/probes on the glass or nylon surface. 
 
To perform the experiment total RNA from both the test and reference 
sample are transformed into complementary DNA (cDNA). The cDNA 
targets are fluorescently labeled with either Cy3– or Cy5–dUTP dyes 
(green and red, respectively), using a single round of reverse transcrip-
tion. The fluorescent targets are then pooled and hybridized, under 
stringent conditions (to avoid unspecific hybridization) to the probes on 
the array (Fig. 1.1B). The hybridization is a competitive process where 
the two cDNA population, test and control, bind to the same spot. The 
read-out of the microarray is performed using a scanner that excites the 
dyes with a specific wavelength and generates an image of the chip. A 
software analyzes the image and the fluorescence intensity for each spot 
is extracted (Fig. 1.1C). The resulting values are interpreted as ratio of 
control versus test and given as log (log ratio). 
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1.4 Affymetrix Arrays 
The techniques for making microarrays differ between manufacturers. Af-
fymetrix has been dominating the market for years and uses a method 
call photolithography, which synthesizes the probe directly on the sup-
port. Photolithography works in a similar fashion as stencil. Agilent, the 
 
Fig. 1.1: How DNA microarrays work? (courtesy of Affymetrix) 
 
 
 17 
 
other principal manufacturer, is using an inkjet method similar to the 
printer technique to spot the arrays. The probes length synthesized is 
the difference between the two platforms. Affymetrix probes are 25 nu-
cleotides long against 60 nucleotides for Agilent. The size factor combined 
with the photolithography technology allows Affymetrix to have the 
highest gene density per chip on the market. Moreover, the hybridization 
technology is very different. Agilent uses the classic two-color (red, green) 
competitive hybridization method whereas Affymetrix uses one-color, 
where only one sample is hybridized per microarray. The expression value 
intensity obtained for the probes are log-ratio for two-color and absolute 
for one-color. 
 
The array architecture is also different for Affymetrix and other provid-
ers like Agilent or Illumina. The probes are organized in probesets repre-
senting the test unit for a gene. A probeset is composed of 11 to 16 per-
fect-match (PM) probes and the same number of mis-match (MM) 
probes. The MM probes are the same as the PM except that the 13th nu-
cleotide is mutated. The purpose of the MM is to measure the signal 
specificity of the PM probe (Fig. 1.2). The MM concept is not a fully sat-
isfying solution to measure unspecific binding signal. Figure 1.3 shows 
the intensity value capture by the PM and MM probe for the probeset 
 
Fig. 1.2 Schematic representation of a Affymetrix probeset. 
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1417945_at representing the gene Oct4. Panel A represents the raw in-
tensity value before background correction. A correlation between the in-
tensity of the PM and the MM is observed. This indicates that the signal 
measure by the MM probes is not entirely due to unspecific binding. 
Panel B and C show the intensity after background correction and nor-
malization, respectively, using the Affymetrix MAS 5.0 algorithm. The 
MAS 5.0 algorithm is defined as the anti-log of the robust average 
(Tukey biweight) of the values log(PM – CT), where CT is equal to MM 
if MM < PM or adjusted to be less than PM when MM > PM. It was 
observe that the MM signal was higher than the PM for approximately 
one-third of all probes (Naef et al., 2002; Irizarry et al., 2003) questioning 
the benefit of using the MM as control. Other studies (Bolstad et al., 
2003; Irizarry et al., 2003) suggest that subtracting MM is not equivalent 
to biological subtraction. 
 
For all these reasons alternative pre-processing methods have been devel-
oped, such as robust multi-array analysis (RMA) (Irizarry et al., 2003). 
The RMA techniques do not use the MM values for the simple reason 
that we do not know how to interpret them. Another normalization 
named GCRMA (Wu and Irizarry, 2004) uses the same approach as 
RMA but evaluates the unspecific binding of the PM probe by looking at 
the GC content of the oligonucleotide sequence of the PM probe. 
GCRMA was shown to give more accurate and precise measures of the 
RNA transcript concentration (Irizarry et al., 2006). 
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Fig. 1.3. Example of the effect of MAS 5.0 algorithm background cor-
rection and normalization on PM and MM probes from Oct4 probeset. 
PM, labeled M, and MM, labeled M, intensities are displayed for every array for differ-
ent cell types. Embryonic stem cell (ESC); induced pluripotent stem cells with two 
fators (2F iPS); Neural stem cells (NSC). (A) Oct4 gene is expected to be highly ex-
press in ESC and 2F iPS cells compared to NSC. (B) PM and MM intensities are af-
fected by background correction for low intensity values. (C) Normalization (scaling to 
300) here affect the 1st 2F iPS array (4th from left) PM and MM intensity. 
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1.5 Thesis Objectives 
This work focuses on DNA microarray data mining and organization. 
The objective was to employ DNA microarray to study gene expression 
changes when hematopoietic stem cells (HSC) or neural stem cells (NSC) 
are (i) induced to undergo normal development or (ii) are reprogrammed 
to adopt novel developmental options, respectively. 
 
First, I wanted to determine the impact of the cytokine transforming 
growth factor type β1 (TGF-β1) on directing HSC to differentiate into 
antigen presenting dendritic cells (DC). HSC development into DC is a 
normal process that occurs in nature and is triggered by TGF-β1. 
 
The second objective of this work was to determine the ongoing changes 
in gene expression when cells are induced to undergo reprogramming, a 
process that does not exist in nature. Therefore, I determine the impact 
of chromatin-modifying drugs on gene expression in NSC that, upon 
treatment, acquire hematopoietic activity. To extend this study a further 
objective was to investigate the changes in gene expression in NSC in-
duced by the reprogramming transcription factors Oct4 and Klf4. Oct4 
plus Klf4 reprogram NSC to an embryonic stem cell (ESC)-like state, 
therefore termed induced pluripotent stem cells (iPS cells). 
 
Microarrays are deposited online in free access upon publication using 
Gene Expression Omnibus (GEO), ArrayExpress (AE) or Stanford Mi-
croarray Database (SMD). These databases store a tremendous amount 
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of information that is underused. Consequently, an additional objective 
of this research was to develop a genuine workflow for semantic annota-
tion of public microarray experiments. The concept aims at the retrieval 
of microarray experiments in an intelligent way by allowing to search by 
cell type, tissue or disease in a semantic manner. 
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2 Methods 
 
 
2.1 Microarray Analysis 
2.1.1 Microarray Pre-Processing  
Scanned GeneChip .DAT files were analyzed with GeneChip Operating 
Software (GCOS, Affymetrix). Data output was further analyzed using 
R, TM4 software (Ihaka and Genteman, 1996; Saeed et al., 2003) or 
GeneSpring (Agilent Technologies, Palo Alto, CA, USA). Gene expression 
values were normalized using RMA (Irizarry et al., 2003), GCRMA (Wu 
and Irizarry, 2004) or MAS 5.0 (www.affymetrix.com). 
2.1.2 Principal Component Analysis 
Principal component analysis (PCA) analysis (Lefkovits et al., 1988) was 
performed using BioConductor (Gentleman et al., 2004). 3D representa-
tions were obtained using R scripts available upon request (da-
vidruau@gmail.com). 
2.1.3 Chromosome Plots 
For hotspot detection the MACAT package of BioConductor (Gentleman 
et al., 2004; Toedling et al., 2004) was used. The geneplotter package was 
used to represent the smoothed expression along the chromosome. 
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2.1.4 Hierarchical Clustering 
Hierarchical clustering was performed using BioConductor and either the 
McQuitty or the average linkage method. Microarray data were correlated 
using 1-|Pearson correlation coefficient| also called cosine distance (Eisen 
et al., 1998) 
2.1.5 Microarray Datasets Publication 
All data sets were submitted to Gene Expression Omnibus database 
(Barrett et al., 2005) (www.ncbi.nlm.nih.gov/geo/; accession numbers 
GSE587, GSE2375, GSE5150, GSE5151, GSE5178, GSE10806, GSE7579, 
GSE12499). 
2.1.6 Gene Ontology Over-Representation 
Gene ontology (GO) over-representation analysis was done with Cy-
toscape (Shannon et al., 2003) and the plugin BINGO (Maere et al., 
2005). Affymetrix ID gene list were converted to UniGene ID and com-
pared to a universe gene list representing the entire microarray. A hyper-
geometric test was performed to estimate over-representation of GO class 
inside the given gene list. Multiple test correction was calculated using 
the Benjamini & Hochberg False Discovery Rate with a significance of 
0.05. 
 
2.2 Text Mining 
A selected subset of the data from GEO were used. Only Affymetrix hu-
man and mouse microarray experiments performed were annotated. The 
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data set represent 19 different types of expression microarrays. Tilling 
arrays, single nucleotide polymorphism arrays and promoter arrays were 
not taken into account, as the workflow takes advantage of expression 
profile similarity. The SOFT files for the different platforms were down-
loaded from GEO in November 2007 and parsed to a different XML for-
mat which is compatible with ProMiner (Hanisch et al., 2005). The cell 
type (CL), the adult mouse gross anatomy (MA) and human disease on-
tologies (DOID) were downloaded from the OBO web site and parsed  
using a PERL script to the dictionary format of ProMiner. The web site 
HyperCLDB and the human and animal cell lines catalogue from the 
DSMZ were adapted to be incorporated into the dictionary as well. 
 
2.3 Semantic Outlier Detection and Label 
Propagation 
All CEL files available for the different platforms were downloaded from 
GEO and pre-processed (Supplementary Table 3.6.1). The arrays were 
normalized using RMA and correlations obtained using 1-|Pearson corre-
lation| (Eisen et al., 1998). Partitioning of the data for calculating the 
SOF value was performed using the PAM algorithm (Kaufman, 1990). 
The SOF program and the knnDelta label propagation algorithm were 
implemented in R (Ihaka and Gentleman, 1996). The empirically pre-
determined δ range was estimated to 0.04 and used when the class cardi-
nality was less than 20 objects. 
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2.4 Database Structure 
We stored our annotation results from the workflow using a SQLite da-
tabase that can be queried with a variety of tools such as RSQLite 
(James, 2008). The database design stores the relation from the 3 on-
tologies used and represents a semantic annotation of Affymetrix expres-
sion arrays (Fig. 2.1). 
 
Fig. 2.1. GEOannot entity relation scheme. 
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3 Results 
 
3.1 Gene Arrays for Gene Discovery 
3.1.1 Mining Gene Expression Data 
The development of DNA microarrays about 15 years ago represents one 
of the most revolutionary inventions in cell biology. DNA microarrays  
allow measuring the expression levels of thousand of genes simultaneously 
thereby generating profiles of mRNA expression for the entire transcrip-
tome of an organism. DNA microarrays are made by robotic disposition 
of complementary DNA (cDNA) in an ordered array on glass or nylon 
membrane supports. Each spot corresponds to a sequence that is highly 
specific for a gene of interest and one single DNA microarray can now 
cover all genes of a given organism. Affymetrix uses photolithography to 
synthesize oligonucleotides directly on the support, thereby achieving 
densities of 1,300,000 oligonucleotides on a 1.3 cm2 surface representing 
37,258 probes corresponding to 12,625 probesets. 
 
This Chapter presents an overview of data mining strategies for microar-
ray gene expression data, including (i) data pre-processing, (ii) methods 
of cluster analysis and (iii) the retrieval of information from knowledge-
based databases and their integration into microarray data analysis 
workflows. 
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DNA microarrays are now being used in scientific research and medical 
diagnosis to address a wide range of very diverse questions. In addition, 
novel applications of DNA microarrays emerged with genome sequencing 
projects that provided the complete sequence information of a given or-
ganism. This genome-wide sequence information now allows measure-
ments that are more than just comparing gene expression levels. For ex-
ample, DNA microarrays are being designed for determining single nu-
cleotide polymorphisms (SNPs) in order to map and relate individual 
genuine variations with a particular disease or phenotype. Another newly 
developed form of DNA microarrays is the tiling array. Such tiling arrays 
cover the organisms’ entire genomic sequence to systematically interrogate 
genomic regions. For example, the seven Affymetrix human tiling arrays 
contain 45 million oligonucleotide probes tiling the entire human genome 
at an average resolution of 35 base pairs. Such tiling arrays are most 
suitable to precisely map novel RNA transcripts and therefore extend the 
information that is obtained by conventional gene expression arrays. Ad-
ditionally, tiling arrays are now being used in chromatin immunoprecipi-
tation (ChIP) studies to map the positions of transcription factors and 
other DNA binding molecules on a global scale. Epigenetics represents an 
very active field of research where tiling arrays are used; allowing to posi-
tion the histone modifications using immunoprecipitation (Mockler et al., 
2005). 
Importantly, DNA microarrays, as a novel genomic platform technology, 
raised multiple challenges: (i) the genome-wide analysis produces huge 
amounts of data that needed to be processed, stored and managed; (ii) 
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advanced data mining techniques have to be employed to assess and un-
derstand the underlying biological events. Frequently, data mining or 
knowledge discovery involves multiple iterative steps (Fig. 3.1.1) 
 
Genome wide microarray studies are systematic and unbiased approaches 
for a given question. Unfortunately, the results produced are often out-
side of the expertise of the investigator. Therefore, the results need to be 
enriched using additional sources of knowledge in order to put data in 
context. However, finding relevant groups of genes of samples by tradi-
tional clustering techniques, such as k-means or agglomerative hierarchi-
cal clustering, is difficult due to the huge dimension of microarray data 
sets. For this reason, dimensionality reduction techniques, like principal 
component analysis (PCA) (Yeung and Ruzzo, 2001) or singular value 
decomposition (SVD), are often used in gene expression mining. (see sec-
tion 3.1.3.1). Subspace clustering is also used in microarray analysis for 
mining of high dimensional data. Subspace clustering selects subsets from 
 
Fig. 3.1.1. Schematic representation of the different steps when mining 
DNA microarray data 
Data preprocessing
Data mining
Interpretation of the results
Data and result representation in graphs
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all dimensions (e.g. samples or patients) to identify groups of genes that 
exhibit similar expression profiles in the selected subset of dimensions 
(see section 3.1.3.2). 
 
Other data mining strategies perform searches no longer on gene expres-
sion values but directly on meta-data, such as gene function. A classical 
method is to consider clustering genes according to their Gene Ontology 
(GO) (Ashburner et al., 2000) category over-representation (Chapter 3.2. 
Fig. 3.2.3). 
 
3.1.2 Data Processing 
3.1.2.1 Challenges in Data Acquisition and Processing 
One of the major challenges in microarray technology is to demonstrate 
the consistency or validity of the measures made. This issue has been ad-
dressed very recently by the MicroArray Quality Control (MAQC) pro-
ject (Shi et al., 2006). This consortium showed that for many manufac-
turers the most recent generation of DNA microarrays allows robust and 
precise monitoring of gene expression of a given biological sample. Thus, 
microarray quality is not a major concern anymore and variability in 
data points is mainly inherent to the biological samples quality and their 
preparation, and to some extent, also influenced by microarray scanning 
and data pre-processing. Factors playing a major role in data consistency 
can be categorize as follows: 
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• Precision (defines the reliability of the measurement) 
• Accuracy (shows how close signal intensity translates into expres-
sion levels for a given gene) 
• Specificity (indicates if the DNA sequence on the array measures 
the expression of the gene it has been designed for) 
• Sensitivity (describes the limitation of detecting low abundant 
transcripts while maintaining an acceptable accuracy and specific-
ity) 
 
All these criteria rely on the experimental design, preparation of the bio-
logical material and data processing. An overview of the current available 
methods for pre-processing microarray raw data and how these data are 
further processed for gene mining is presented in the following sections. 
3.1.2.2 Data Pre-Processing: An Overview 
Affymetrix microarray received most of the attention from the bioinfor-
matic community because of its pioneering role in the field. The Affy-
metrix platform uses one-color microarrays as opposed to two-color mi-
croarrays. Briefly, for one-color microarray, one RNA sample is hybridized 
to a single array while for two-color microarrays two RNA samples are 
hybridized competitively to the same array. These two different ap-
proaches imply a difference in signal interpretation. The signal obtained 
from two-color microarray is the ratio of the signals from the test sample 
to the control sample. One-color technology measures are absolute ex-
pression values. High-level signal processing for Affymetrix arrays can be 
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separated in two steps: background noise correction and normaliza-
tion/summarization. 
 
The first step, background noise correction is a particularly difficult 
problem. Starting from the raw fluorescence intensity values extracted 
from the scanner image, background correction combines two contradic-
tory effects; (i) it increases accuracy and (ii) lowers the precision by in-
creasing the variance between replicates (Bolstad et al., 2005). 
 
In the next step raw expression levels need to be normalized in order to 
be comparable across samples. There are numerous normalization meth-
ods that often rely on platform specific features such as one-color or two-
colors array design (Quackenbush, 2002; Bolstad et al., 2003; Gentleman 
et al., 2005; Irizarry et al., 2006). Yet, it is important to point out that a 
direct and quantitative comparison between the expression levels of dif-
ferent genes on the same microarray is not possible even after normaliza-
tion. Each single probe/gene on the microarray hybridizes with the target 
sequence with a different specificity. Consequently, the relation between 
signal and transcript concentration is not linear for low and high trans-
cript concentrations and additionally unique for every probe. Microarray 
technology accurately measures variations in the abundance of a particu-
lar transcript in different biological samples and thus, up- or down-
regulation of genes. The information obtained by comparing the signal 
intensities of different genes of the same biological sample hybridized to 
the same array is irrelevant, as microarray do not give quantitative re-
sults. 
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3.1.2.3 Comparing Gene Expression Profiles 
Following normalization one would like to identify genes or samples that 
exhibit a similar expression profile e.g. by performing gene clustering. At 
this stage it is important to know that the choice for the distance or 
similarity measure is crucial before any clustering is performed. Thus, 
gene clustering can lead to different interpretations depending on the 
similarity measures applied. There are different types of dis-
tances/correlations that exhibit different properties. Frequently, metrics 
are categorized into three types: (i) Minkowski metrics, (ii) parametric 
correlation and (iii) non-parametric correlation. From the Minkowski 
metrics (1) for p=1 and p=2 one can obtain the Manhattan and Euclid-
ean distances, respectively. 
 
Minkowski metrics (1) 
 
 
For the Minkowski metrics the distance between samples is the same for 
relative and absolute expression measures (two-color microarrays). This 
does not hold for the distance between genes. On the other hand, dis-
tances based on the Pearson correlation (2) yield the same distance be-
tween genes for both relative and absolute measures but not for the dis-
tance between samples. Considering these facts and that the main inter-
est is in classifying similar multidimensional gene expression profiles, the 
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most widely used metrics are the correlations, such as Pearson correla-
tion. 
 
The Pearson correlation (2) and its related correlations, like the cosine 
distance used by Eisen et al. (Eisen et al., 1998), give good results when 
clustering aims at identifying genes with similar expression profiles inde-
pendently of the scale. 
 
Pearson correlation coefficient (2) 
 
 
The Pearson correlation and their derivatives are parametric and able to 
measure linear relations between gene vectors of expression values but are 
sensitive to outliers. Pearson correlation can also be used to classify sam-
ples with the assumption that the populations are normally distributed. 
A normal distribution of expression values is in fact observed in the large 
majority of microarray experiments performed today (Giles and Kipling, 
2003). Parametric correlation measures can, due to their sensitivity to 
outliers, give non-homogeneous cluster solutions. In this case non-
parametric correlations, such as Spearman rank correlation or Kendall’s t 
rank correlation, are preferred. 
 
Often microarray experiments have an underlying structure determined 
by covariate (supplementary) information such as treatment, cell or tis-
sue type, or time. Those features can be incorporated into the similarity 
 
 
34     
 
measure as weight to relate expression profiles in a more relevant manner 
(Bolshakova et al., 2005; Homayouni et al., 2005). 
 
Furthermore, to create even more meaningful clusters, genes can be 
linked to knowledge-based databases such as biological pathway informa-
tion or by searching for literature co-citation in available publications. 
The general idea behind text mining for gene co-citation is that genes 
that are cited in the same paper might be functionally related (Jenssen et 
al., 2001). Text mining on the available online medical literature to ex-
tract gene function annotation is a particularly dynamic field of bioin-
formatics (Masys et al., 2001; Yandell and Majoros, 2002; Hanisch et al., 
2005). 
 
 
Fig. 3.1.2. Schematic representation of clustering algorithms 
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3.1.3 Gene Discovery by Gene Clustering 
Gene clustering aims to identify groups of genes exhibiting common ex-
pression profile in complex data sets. There is no universal clustering al-
gorithm that fits all needs and consequently multiple methods exist. 
Clustering algorithm can essentially be classified into hierarchical and 
non-hierarchical clustering (Fig. 3.1.2). Hierarchical clustering can be gen-
erated by two ways: either agglomerative or divisive, depending whether 
the tree is built from bottom to top or vice versa (Fig. 3.1.3). Figure 
3.1.3 shows the agglomerative approach applied to eight microarrays for 
neuronal stem cells (NSC), embryonic stem cells (ES cells) and induced 
 
Fig. 3.1.3. Agglomerative and divisive hierarchical clustering 
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pluripotent stem cells derived from neuronal stem cells by two factors 
(iPS 2 Factors; see Chapter 3.4). 
 
Agglomerative hierarchical clustering is the most commonly used method 
for gene expression data (Kaufman, 1990). It is often associated with a 
heatmap representation showing the gene expression profile in a graphi-
cal manner (Eisen et al., 1998). Different linkage methods exist to join 
the groups when building the tree. A list of available linkage methods is 
given in Table 3.1.1. 
There are three types of non-hierarchical clustering algorithms: (i) parti-
tioning methods, (ii) hybrid methods combining partitioning and hierar-
Table 3.1.1. Linkage methods commonly used for hierarchical clustering 
Single Shortest distance or nearest neighbor (McQuitty, 1966) 
Average Unweighted average distance (UPGMA) also called Group 
average distance 
Weighted Weighted average distance (WPGMA) 
Complete Furthest distance/neighbor (Ward, 1963) 
McQuitty Similar to single method (Lance, 1966) 
Ward Inner squared distance; for interval-scaled measurements 
(Han and Kamber, 2006) 
Median Weighted pair-group method using centroid (WPGMC) 
Centroid Unweighted pair-group method using centroid (UPGMC) 
Flexible Generalization of the others (Han and Kamber, 2006) 
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chical methods and (iii) further methods such as density based clustering 
or subspace clustering (Han and Kamber, 2006). 
3.1.3.1 The Curse of Dimensionality 
Hierarchical clustering methods are the most commonly used clustering 
techniques in microarray mining. They perform well on data sets with 
few dimensions. However, when the data set size grows these methods 
suffer from the “curse of dimensionality” like every other clustering 
method (Beyer et al., 1998). This problem states that with the increase 
of dimensionality, distances between objects become less meaningful and 
objects become harder to separate. Dimensionality reduction methods can 
be classified into two categories: 
1. Feature extraction: creating a subset of new features by combining 
existing features 
a. Signal representation: aims at representing the sample ac-
curately in a lower-dimension space 
b. Classification: the goal is to increase the class-
discriminatory power in a lower-dimensional space 
2. Feature selection: choosing a subset of all the features (the most 
informative) 
Feature extraction methods are separated in two types as describe above: 
(1) Signal representation such as principal component analysis 
(PCA)(Jolliffe, 2002). The principal components (PC) obtained from the 
PCA capture in a decreasing order the variance of the data set. Conse-
quently, the first PC represents an ordered list of genes that maximize 
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the difference between the samples. This method is often used to under-
stand the relation between microarray data sets. PCA is more suitable 
than hierarchical clustering for high dimensional space. 
(2) Classification feature extraction methods, like linear discriminant 
analysis (LDA), can help to reduce the number of dimension (genes or 
samples) to cluster, while trying to keep most of the information con-
tained in the original data set. 
3.1.3.2 Subspace Clustering 
Subspace clustering is another interesting technique that tries to find 
clusters in a subset of dimensions. This means finding relevant gene clus-
ters when considering only a subset of the microarray samples. However, 
the last generation of mouse microarray measures 45,000 probesets at 
once and the number of microarrays in one experiment can reach hun-
dreds of samples. Subspace clustering performance does not scale well for 
this size of microarray data sets. The last advanced algorithms in sub-
space clustering like eDUSC (Assent et al., 2008) would not perform well 
on a classic dataset of 45,000 probesets by 20 arrays. An advanced clus-
tering method applied in microarray mining is the frequent pattern min-
ing technique, such as biclustering (Cheng and Church, 2000). Biclus-
tering algorithm, such as pCluster works on the genes and on the condi-
tions to produce subclusters solution in a reasonable running time on 
small data sets. The pCluster algorithm has a time complexity 
O(M2NlogN + N2MlogM) where M is the number of microarray and N 
the number of gene. The pCluster algorithm has a quadratic complexity 
and consequently cannot be applied to the last generation of microarray 
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experiments in full dimensional space (Wang et al., 2002; Yang et al., 
2002; Madeira and Oliveira, 2004). 
 
However, the samples have often a cardinality below 20 and an intrinsic 
organization, such as time course or cell type comparison. In addition, 
microarrays are made in replicate. In such case, the researcher is using 
simple filtering techniques to find relevant groups of genes. For example, 
a classic filtering would be to select genes with two-fold up-regulation 
with a change p-value below 0.05 between two conditions (disease vs 
healthy). 
3.1.3.3 Making Sense from Gene Lists 
Clustering can answer questions at different levels of granularity during 
the analysis process. One can relate global gene expression profiles from 
one sample to the others and draw a hypothesis. Another approach is to 
select the genes that are the most differentially regulated between the 
different conditions and try to make sense out of it. Usually, those lists 
contain an overwhelming number of genes that are often falling outside 
of the expertise of the investigator. One approach to understand the 
composition of the gene list requires linking and describing genes of inter-
est by using ontologies. Ontologies organize knowledge about a particular 
domain in a defined and structured manner. In biology probably the 
most famous ontology is the Gene Ontology (GO). GO contains three 
sub-categories describing each a specific domain of knowledge: cellular 
component, biological process and molecular function. Genes can belong 
to more than one category within each of the main sub-categories. Nu-
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merous tools make use of the GO classification and are listed on the GO 
web page (www.geneontology.org). The majority of these software tools 
perform statistical tests on the genes of interest by searching for enriched 
GO classes. An example is outlined in Maere et al. (Maere et al., 2005), 
the software, BINGO, looks for over-representation of GO categories in-
side the gene list given, compared to a normal random distribution. The 
results can be displayed in form of directed acyclic graph (DAG), where 
the size of the node is proportional to the number of genes in the cate-
gory (see Fig. 3.2.3). The color of the node follows a scale indicating the 
over-representation degree of the GO category. Other methods propose to 
incorporate knowledge from GO to assess or improve a cluster interpreta-
tion (Huang and Pan, 2006). 
 
In summary, the results obtained by clustering, either hierarchical or 
non-hierarchical, are highly dependent on the metric (distance or similar-
ity/dissimilarity) used to quantify the difference between the features. It 
is important to note that all clustering techniques described here are un-
supervised methods. Supervised methods, such as those employed in ma-
chine learning techniques, are not often used in gene expression mining. 
This type of algorithm requires training to recognize for example the dif-
ferent types of disease on a curated database of all the disease types. Ma-
chine learning methods are mainly employed for medical applications 
where one wants to classify newly generated sample from patients within 
a given cell type (tumorous or healthy) or disease state.
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3.2 Genomics of TGF-β1 Signaling in Stem Cells 
Commitment and Dendritic Cell Development 
 
 
3.2.1 Antigen Presenting Dendritic Cells 
Dendritic cells (DC) are a population of highly specialized immune cells 
that play a determining role in controlling the balance between immunity 
and immunological tolerance (Banchereau et al., 2000; Steinman et al., 
2003). DC encounter and capture pathogens in peripheral tissues trigger-
ing their activation and migration to the lymphoid organs where they 
present the processed antigens in the context of MHC class I and II 
molecules to elicit antigen specific T cell responses. DC are also believed 
to take up endogenous antigens that are presented and this is important 
for induction and maintenance of immunological tolerance. 
 
Over the past several years specific DC subsets have been identified that 
differ in surface phenotype, function, activation state and anatomical lo-
cation (Zenke and Hieronymus, 2006; Shortman and Naik, 2007). Inter-
stitial DC (now also referred to as conventional DC, cDC) are present in 
almost all tissues. Langerhans cells (LC) represent the cutaneous contin-
gent of DC located in epithelial tissues, such as skin and conjunctiva, oral 
and respiratory mucosa. Plasmacytoid DC (pDC), found e.g. in blood, 
spleen and lymph nodes, represent yet another DC subtype which was 
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initially characterized by the production of large amounts of type 1 inter-
feron in response to viruses and bacteria. 
All DC subsets originate from hematopoietic stem cells in bone marrow 
(Fig. 3.2.1). However, more recent studies suggested that pools of DC 
precursor cells are also present in lymphoid organs (e. g. spleen) and non-
lymphoid tissues, like skin (Zenke and Hieronymus, 2006; Shortman and 
Naik, 2007). These studies revealed a considerable plasticity of DC devel-
opment. DC originate from both lymphoid and myeloid precursors but 
develop also via pathways that are distinct from the conventional lym-
phoid/myeloid branches of the hematopoietic system (Zenke and 
Hieronymus, 2006; Shortman and Naik, 2007). Furthermore, the cur-
rently emerging concept indicates that all DC subset originate from a 
population of Flt3+ precursors that abundantly express the Flt3 recep-
 
Fig. 3.2.1. Hematopoietic cell fate map and DC development. 
HSC: Hematopoietic stem cell; LT-HSC: Long-term repopulating HSC; ST-HSC: Short-
term HSC; CLP: Common lymphoid progenitor; CMP: Common myeloid progenitor; and 
Flt3+ M-CSFR+ c-kit low: common DC progenitor. 
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tor tyrosine kinase (D'Amico and Wu, 2003; Manz, 2006; Onai et al., 
2006; Fig. 3.2.1). 
 
Cytokines represent a class of proteins that bind to cognate cell surface 
receptors and trigger complex signaling cascades to regulate gene expres-
sion and cell fate decisions. A number of cytokines have been implicated 
in DC development, including Flt3 ligand (Flt3L) and transforming 
growth factor, type-β1 (TGF-β1), as demonstrated by the analysis of ge-
netically modified mice. Flt3L-/- mice show massively reduced frequencies 
of cDC and pDC (McKenna et al., 2000; Manz, 2006) and TGF-β1-/- 
mice lack LC (Borkowski et al., 1996). Furthermore, a hematopoietic spe-
cific ablation of STAT3, a downstream component of Flt3 signaling, also 
compromised DC development (Laouar et al., 2003). Similarly, mice defi-
cient for the helix-loop-helix (HLH) transcription factor Id2 (inhibitor of 
differentiation/DNA binding 2), a downstream target of TGF-β1 signal-
ing, lack LC (Hacker et al., 2003) and thus show a similar phenotype as 
TGF-β1-/- mice. All these studies demonstrate the impact of Flt3-
STAT3 and TGF-β1-Id2 signaling on DC development and subset speci-
fication. 
 
TGF-β1 is a multifunctional cytokine involved in a variety of biological 
processes, including cell cycle control and cell differentiation, immune 
modulation and apoptosis (Fortunel et al., 2000). TGF-β1 binding to its 
receptors activates TGF-β receptor II which leads to TGF-β receptor I 
phosphorylation and anchoring of receptor-activated Smads (R-Smads), 
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such as Smad2/3, and their phosphorylation (ten Dijke and Hill, 2004; 
Larsson and Karlsson, 2005). Smad phosphorylation leads to the forma-
tion of a heterodimeric complex with the common mediator Smad 4 (Co-
Smad) and its translocation into the nucleus, where Smads bind to spe-
cific regulatory DNA sequences and regulate gene transcription. A third 
class of Smads, the inhibitory Smads (I-Smads), such as Smad6/7, blocks 
phosphorylation of R-Smads by their receptors and thus act by inhibit-
ing TGF-β1 signaling. 
 
In this work DC were subjected to gene expression profiling with DNA 
microarrays and analyze for TGF-β1 target genes with an impact on DC 
development. 
 
3.2.2 TGF-β1 Signalling in Stem Cell Commitment and 
Dendritic Cell Development 
CD34+ cells from cord blood were amplified with a stem cell fac-
tor/cytokine cocktail (10-14 days) and 1-2x108 progenitor cells (in the fol-
lowing referred to as hematopoietic progenitor cells, HPC) were routinely 
obtained (Hacker et al., 2003; Ju et al., 2003; Ju and Zenke, 2003). Cells 
were then induced to differentiate into DC with granulo-
cyte/macrophage-colony stimulating factor plus interleukin 4 (GM-
CSF+IL-4) (6 days). HPC and DC were treated with TGF-β1 for 4, 16 
and 36 hours, RNA was isolated and subjected to DNA microarray 
analysis (GeneChip arrays, Affymetrix). 
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Gene expression data were analyzed by principal component analysis 
(PCA) that projects global gene expression data in three dimensions 
(Fig. 3.2.2). PCA separated HPC and DC data sets. Additionally, PCA 
demonstrates that TGF-β1 had a major impact on gene expression in DC 
while the influence on HPC was less pronounced. HPC form a cluster of 
closely associated data points irrespective whether cells were treated with 
TGF-β1 or not. In DC most of the changes in gene expression were in-
duced within 4 hours of TGF-β1 treatment, while the 16 and 36 hours 
TGF-β1 data points cluster close to untreated DC. 
 
Given the observation that TGF-β1 had a major influence on gene ex 
 
Fig. 3.2.2. Principal component analysis (PCA) of HPC and DC treated 
with TGF-β1. 
Global gene expression of HPC and DC treated with TGF-β1 for various periods of time 
(HPC: 4 and 16 hours; DC; 4, 16 and 36 hours) or left untreated (0 hour) as indicated. 
PCA was performed with all 10,000 genes on the microarray, irrespective whether they 
were expressed or not. Each data point represents an individual microarray experiment. 
The first 3 components, that capture 99.3% of the variability in the data sets, are shown. 
(B) clockwise rotation of the image in (A) by 90 degree. 
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pression in DC, we focused our further analysis on genes that were dif-
ferentially regulated in DC. 2204 genes were found to be up- or down-
regulated with TGF-β1 by more than two fold after 4, 16 or 36 hours of 
treatment. Thus, the 2204 differentially regulated genes were subjected 
to GO over-representation analysis (Fig. 3.2.3). Interestingly, most of the 
TGF-β1 regulated genes were found in GO categories related to immune 
and defense responses, responses to stress, wounding and pathogens etc. 
 
Fig. 3.2.3. Gene ontology (GO) over-representation analysis of TGF-β1 
regulated genes in DC. 
2204 genes were fond differentially regulated by TGF-β1 in DC. Color scale indicates con-
fidence (corrected p-value) in the over-representation of the respective GO class; white 
nodes are not over-represented. The size of the node is proportional to the number of 
genes present in the individual category. 
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but not in GO categories related to for example cellular metabolism and 
physiological processes. The analysis showed also an influence of TGF-β1 
on cell proliferation. In summary, these results provide initial information 
on the gene categories affected by TGF-β1 in DC. 
 
Kyoto Encyclopedia of Genes and Genomes (KEGG; http:// 
www.genome.jp/kegg/) represents a knowledge-based database that con-
tains information on gene networks including a large number of signaling  
and metabolic pathways. Thus, microarray data can be linked to KEGG 
database for exploring gene expression data for specific pathways. There-
fore, DC expression data were investigated for their contribution to the 
 
Fig. 3.2.4. KEGG pathway for TGF-β1 signaling with gene expression 
variation map. 
Schematic representation of the TGF-β1 signaling pathway from KEGG database. 
Changes in gene expression upon TGF-β1 treatment (4 hours) of DC are displayed in 
color code (e.g. red, increase in gene expression) and several TGF-β1 target genes are 
shown. 
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canonical TGF-β1/Smad signaling pathway (Fig. 3.2.4). Changes in gene 
expression are displayed in color code. As expected the expression of a 
number of known TGF-β1 target genes were found to be induced, such 
as PAI-1. In addition, the analysis identified several novel TGF-β1 target 
genes that are currently being further investigated. 
 
3.2.3 Searching for TGF-β1 Target Genes in Dendritic 
Cell 
To obtain further insights into the identity of the TGF-β1 induced 
genes, the 2204 differentially regulated genes were subjected to hierarchi-
cal cluster analysis and data were displayed in heatmap (Fig. 3.2.5A). 
This analysis revealed a distinct cluster of genes that were induced by 
TGF-β1 within 4 hours and which expression declined at 16 and 36 
hours (cluster IV). Clusters I and V contain genes that were induced by 
TGF-β1 with slower kinetics and achieved high expression after 16 and 
36 hours. Cluster II and III show down-regulated genes (Fig. 3.2.5A). 
 
Frequently, immune cells, including DC, are characterized by their cell 
surface marker expression. Thus, TGF-β1 treated DC were analyzed for 
changes in expression of CD molecules. Hierarchical cluster analysis revea-
led classes of up- and down-regulated genes (Fig. 3.2.5B). Up-regulated  
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genes comprised several activation markers such as CD40, CD44, CD83, 
CD226, ALCAM and ICAM. Down-regulated genes were e.g. CD14, 
CD62L/SELL/L-selectin and angiotensin converting enzyme (ACE). In-
terestingly, the most dramatic effects of TGF-β1 on CD gene expression 
were observed in DC and there were only marginal changes in HPC, 
which is very much in line with the PCA result (Fig. 3.2.2). 
 
 
Fig. 3.2.5. Heatmap view of hierarchical clustering of differentially regu-
lated genes in TGF-β1 treated DC. 
Each row represents one gene and the color indicates expression levels. Red and blue, 
higher and lower expression values, respectively, of a specific gene in comparison to its 
mean expression value. (A) Hierarchical cluster analysis of 2204 genes that were differen-
tially regulated by more than two fold within 4, 16 or 36 hours of TGF-β1 treatment. 
(B) Hierarchical cluster analysis of 52 differentially regulated CD molecules in TGF-β1 
treated progenitor cells and DC. 
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Smad transcription factors represent key components of TGF-β1 signal-
ing and initial DNA microarray experiments demonstrated the expression 
of several Smad factors in DC (Accession No. GSE5178). TGF-β1 effec-
tively induced Smad2/3 phosphorylation within five min indicating that 
the canonical TGF-β1/Smad signaling pathway is active in these cells 
(Fig. 3.2.6A). We then searched for transcription factors regulated by 
more than two fold under TGF-β1 treatment, including various DNA 
binding factors, co-activators and co-repressors, chromatin modifying 
proteins, basic transcription factors and components of the RNA polym-
erase complex.  
 
 
Fig. 3.2.6. TGF-β1/Smad signaling in 
DC and hierarchical cluster analysis 
of TGF-β1 target genes. 
(A) DC at day 6 of differentiation were 
treated with TGF-β1 for 0, 5, 15, 30, 60, 120 
min. Immunoblot analysis was performed 
with phospho-Smad2/3 and total Smad2/3 
specific antibodies (in collaboration with 
X.S. Ju, Institute for Biomedical Engineer-
ing, department of Cell Biology, RWTH 
Aachen; Ju et al., 2008). (B) Hierarchical 
cluster analysis of transcription factor ex-
pression in DC (day 6) treated with TGF-β1 
for 4, 16 and 36 h, or left untreated, by Af-
fymetrix GeneChip arrays. The expression 
pattern of 147 transcription factors that ex-
hibits a change in expression levels by more 
than 2 fold is shown. Each gene is repre-
sented by a single row of colored boxes. 
Green, transcription levels below median; 
black, transcription levels equal to median; 
red, transcription levels higher than median. 
Cluster I and II: up-regulated genes with fast 
and slow kinetics, respectively; Cluster III: 
down-regulated genes. 
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This analysis identified 147 transcriptional regulators that were sub-
jected to a hierarchical cluster analysis (Fig. 3.2.6B). Cluster I contains 
transcription factors effectively induced after 4 hours of TGF-β1 treat-
ment, whereby their expression declined after 16 and 36 hours. It in-
cludes Id1, Id2, ABF1, Runx3, IRF-1, IRF-8, STAT1 and STAT5. Clus-
ter II encompasses genes induced by TGF-β1 with slower kinetics, achiev-
ing high expression values after 16 or 36 hours, and includes Runx1, Myb 
and STAT2. Down-regulated genes are shown in cluster III, containing 
for example the HLH transcription factor Lyl1. 
 
In conclusion, the genome-wide analysis of TGF-β1 responses in DC un-
covered distinct expression patterns and gene categories that will be most 
useful for a more detailed analysis. Our data revealed a critical role of the 
TGF-β1/Smad/IRF-8 signaling pathway in DC development and func-
tion. Further functional studies are expected to pave the way for a more 
comprehensive understanding of TGF-β1 signaling in DC development 
and function. 
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3.3 Genomics of Somatic Cell Reprogramming 
 
 
Stem cells are functionally characterized by their high self-renewal ac-
tivity and their multilineage differentiation potential (Weissman, 2000; 
Boiani and Scholer, 2005). In multicellular organisms specific stem cell 
types with distinct developmental potentials occur during development. 
Transient pluripotent cells, which can differentiate into derivatives of all 
three germ layers, are generated during blastocyst development (Fig. 
3.3.1). Adult stem cells, developing at later stages, are more restricted in 
their potential, since they can differentiate into progenitors and mature 
effector cell types of only one stem cell system. Adult stem cells have been 
identified in a variety of tissues in the adult organism and are important 
for lifelong tissue homeostasis and repair (Weissman, 2000). Adult stem 
cells show specific functional properties and express specific gene pattern 
that are distinct from pluripotent embryonic stem cells (ESC) and ter-
minally differentiated cells. Pluripotency is a transient feature that be-
comes increasingly restricted during development (Boiani and Scholer, 
2005). ESC are invaluable tools for generating transgenic and knockout 
mice and for studying pluripotency mechanisms. ESC have remarkable 
properties: (i) they are ‘immortal’ in the sense that they can be main-
tained alive in culture indefinitely; (ii) their cellular properties do not 
change over time as they retain a normal karyotype and morphology. 
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ESC cultures can be regenerate from a single cell and upon implantation 
into a recipient animal ESC give rise to teratoma. Frequently, ESC are 
genetically modified in culture and then re-injected into a blastocyst. The 
blastocyst upon successful implantation into the uterus of a recipient 
animal will generate a chimaeric animal. A chimaeric animal contains 
both types of cells randomly spread in the animal. If the chimaeric animal 
exhibits germ line transmission upon breeding, the next generation will 
be fully transgenic and no longer chimaeric. 
 
ESC self-renewal and differentiation are regulated by specialized regula-
tory circuitry, involving transcriptional regulators, including Oct4, Sox2, 
Nanog and Polycomb group (PcG) proteins, and various signaling path-
ways, e.g. STAT, BMP and Wnt signaling (Boiani and Scholer, 2005; 
Boyer et al., 2005; Boyer et al., 2006; Ivanova et al., 2006; Loh et al., 
2006). Recent studies demonstrated that fetal and adult cells are repro-
 
Fig. 3.3.1. Origin of stem cells in mammalian embryo. Adapted from 
(Boiani and Scholer, 2005) 
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grammed to pluripotency by ectopic expression of four factors (Oct4, 
Klf4, Sox2 and c-Myc), referred to as induced pluripotent stem (iPS) cells 
(Takahashi and Yamanaka, 2006; Maherali et al., 2007; Okita et al., 2007; 
Wernig et al., 2007). iPS cells acquired an epigenetic state similar to ESC 
and can form viable chimaeras and contribute to the germline. 
 
3.3.1 Somatic Cell Reprogramming: Induction of Pluri-
potency 
Generation of ESC involves sacrifying an embryo. Human ESC (hESC) 
originates from embryos generated in excess of patients benefiting from 
medically assisted reproduction procedures. This method has allowed the 
generation of numerous stable hESC lines for research purpose. However, 
those hESC are not suitable for stem cell therapy, as they do not match 
the immunophenotype of the patient. For this reason alternative ap-
 
Fig. 3.3.2. Reprogramming and induction of pluripotency in somatic 
cells 
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proaches to generate pluripotent stem cells have been developed (Fig. 
3.3.2). The oldest method is the somatic cell nuclear transfer (SCNT), a 
procedure of transferring a donor adult somatic cell nucleus into an un-
fertilized enucleated oocyte (Jaenisch and Young, 2008). The medical pro-
cedure to obtain unfertilized eggs from women is an invasive surgical op-
eration, thus limiting the available number of oocytes. 
 
3.3.2 Induction of Pluripotency by Cell Fusions 
Fusion of ESC with somatic cells, such as Flt3+ hematopoietic stem cells 
(Flt3+HSC), produce hybrid cells that are pluripotent and exhibit prop-
erties of ESC, but retained properties of Flt3+HSC. A recent genome-
wide study performed in our laboratory showed that the resulting 
Flt3+ESC/HSC hybrids retained expression profiles similar to ESC and 
Flt3+HSC. A PCA of their global expression profile compared to other 
reprogrammed cells show that there is different degrees of reprogram-
ming among the hybrids clones (Fig. 3.3.3). Expression arrays measure 
up to 45,000 genes at the same time reaching a high coverage density al-
lowing the gene expression profile to be mapped along the chromosome in 
a meaningful way. We observed that the gene expression profile of 
Flt3+ESC/HSC cells is highly similar to the ESC profile (Fig. 3.3.4). 
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Flt3+ESC/HSC hybrids clones are also stable tetraploid (4N). This is a 
major obstacle for their use in medical application. It has been observed 
that some Flt3+ESC/HSC hybrid clones spontaneously revert to a dip-
loid state (2N).  
 
 
 
Fig. 3.3.3. PCA analysis of Flt3+ESC/HSC hybrids clones in correlation 
with other reprogrammed cells. 
Flt3: Flt3+HSC; Hybrids: Flt3+ESC/HSC hybrids; ESC: embryonic stem cells; NSC 4F 
iPS: iPS cells derived from NSC transfected with four factors (Oct4, Sox2, Klf4, c-Myc); 
NSC 2F iPS cells: iPS cells derived from NSC transfected with two factors (Oct4, Klf4); 
MEF 4F iPS cells: iPS cells derived from mouse embryonic fibroblast (MEF) transfected 
with four factors (Oct4, Klf4, Sox2 and c-Myc) 
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Fig. 3.3.4. Gene expression mapping along chromosome 3, 4 and 6 
Gene expression for ESC, Flt3+HSC and Flt3+ESC/HSC hybrids plotted along their 
respective chromosomes. Red lines indicate chromosomal location of three genes (Sox2, 
Klf4 and Lin28), known to play a role in pluripotency. 
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3.3.3 Induced Pluripotent Stem Cells (iPS cells) 
Induced pluripotent stem (iPS) cells were first reported in 2006 by Ta-
kahashi and Yamanaka (Takahashi and Yamanaka, 2006). They repro-
grammed mouse embryonic fibroblast (MEF) using four transcription 
factors: Oct4, Klf4, Sox2 and c-Myc. It took a year until the discovery 
was reproduced by two different teams and extended by the original 
group from Yamanaka (Maherali et al., 2007; Okita et al., 2007; Wernig 
et al., 2007). In 2007 the Takahashi group and the Thomson group 
brought their discovery from mouse to human (Takahashi et al., 2007; 
Yu et al., 2007; Park et al., 2008). iPS cells exhibit similar properties of 
ESC and can produce chimaeric mouse. However, iPS cells are not com-
pletely identical to ESC when comparing their global gene expression pro-
file and DNA methylation profile (see Chapter 3.5 for detailed analysis). 
 
3.3.3.1 The Four-Factor Cocktail for Somatic Cell Re-
programming 
Mouse and human skin fibroblast can be reprogrammed using four tran-
scription factors as describe above. However, the usage of the oncogene c-
Myc has raised some concerns about potential tumor formation in chi-
maeric mice. Consequently, generating iPS cells with fewer factor(s) or an 
alternative method became a major topic of interest after the publication 
of the original discovery. Nakagawa and colleagues reported in 2008 the 
generation of human and mouse iPS cells with three factors only (Oct4, 
Klf4, Sox2) (Nakagawa et al., 2008). Although the mouse coming from 
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three factors iPS cells did not developed tumors, the number of iPS cells 
obtained was significantly lower than with four factors. To reduce the 
number of factors even further a new reprogramming starting point was 
necessary. Some adult stem cells such as neural stem cells (NSC) already 
express elevated levels of endogenous of Sox2 and c-Myc (Ruau et al., 
2008). From this observation, Kim and colleagues (Kim et al., 2008) 
transformed NSC with only two factors, Oct4 and Klf4, and obtained 
iPS cells (2F iPS) 14 days after infection with the retroviral construct 
(see Chapter 3.5 for detailed analysis). 
 
Generating iPS cells frequenly involved retroviruses carrying the repro-
gramming transcription factors. The insertion of the transgene in the 
host genome raised concerns about the re-activation of genes or the dis-
ruption of others (Varas et al., 2008). It has been shown that the inser-
tion sites of the virus constructs are random and thus the possibility of 
activating an oncogene upon the infection is not negligible. Alternative 
solutions avoiding retroviral integration appeared recently (Okita et al., 
2008; Stadtfeld et al., 2008) using expression plasmid to produce the four 
reprogramming factors in the cell. Other solutions propose to use chro-
matin modifying drugs in addition to retroviral transduction of Oct4 and 
Klf4 to reprogram NSC (Shi et al., 2008). In our study (Chapter 3.4), we 
used epigenetic modifying agents and observed reprogramming of NSC to 
an “ES cell” state-like (Ruau et al., 2008). 
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3.3.3.2 Induced Pluripotent Cells Without Forced Ex-
pression of Reprogramming Factors 
Recent studies report the generation without any reprogramming tran-
scription factors (Shamblott et al., 1998; Park et al., 2004; Guan et al., 
2006; Conrad et al., 2008; Durcova-Hills et al., 2008; Kanatsu-Shinohara 
et al., 2008). The method starts with adult germline stem cells (GSC, 
also referred to as spermatogonial stem cells, SSC; Fig. 3.3.2 right) iso-
lated from testis and cultured in leukemia inhibitory factor (LIF) con-
taining medium. GSC acquired ESC properties after three to four weeks 
in stem cell culture conditions and are referred to as germline pluripotent 
stem (gPS) cells. gPS cells can contribute to germline and all other tis-
sues in mouse. Our previous work demonstrated that the number of re-
programming transcription factors can be reduced when target cells al-
ready abundantly express some of these factors (see section 3.5.1 and 
(Kim et al., 2008; Kim et al., 2009). Accordingly, cells that already ex-
press Oct4, the key reprogramming factor, iPS cells or iPS-like cells are 
obtained without exogenous factors, just by appropriate selection proce-
dures. 
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3.4 Pluripotency Associated Genes Are Reacti-
vated by Chromatin-Modifying Agents in Neu-
rosphere Cells 
 
 
Over the past few years several studies reported on an enlarged develop-
mental potential of adult stem cells that extends to other tissues than 
the tissue of origin (Graf, 2002; Wagers and Weissman, 2004; Vieyra et 
al., 2005). For example, HSC were reported to generate muscle, liver and 
neural cells. However, many of these initial observations were not repro-
duced and are now being met with skepticisms. Cells were found to 
adopt the phenotype of other cells e.g. due to spontaneous cell fusion 
(Terada et al., 2002; Ying et al., 2002; Wang et al., 2003; Vieyra et al., 
2005) and/or epigenetic alterations (Morshead et al., 2002). Furthermore, 
epigenetic disregulation is also observed during stem cell aging 
(Chambers et al., 2007). 
 
In a previous study we observed that transient epigenetic modification of 
neurosphere cells by the chromatin modifying agents trichostatin A 
(TSA) and 5-Aza-2’-deoxycytidine (AzaC) make them acquire hema-
topoietic activity in vivo, albeit with low frequency (Schmittwolf et al., 
2005). The TSA/AzaC induced hematopoietic activity was long-term, 
multi-lineage and transplantable. Similarly, in vitro cultured human 
CD34+ hematopoietic stem/progenitor cells retain the ability to repopu-
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late immunodeficient mice if pretreated with AzaC and HDAC inhibitors 
(Milhem et al., 2004; Araki et al., 2006). TSA and AzaC, by inhibiting 
histone deacetylation and DNA methylation, respectively, generate an al-
tered, transcriptionally active chromatin structure that is expected to af-
fect global gene expression and thus to influence cell fate decisions (Fig. 
3.4.1). Frequently, treatment with both chromatin modifying agents is 
required for reactivation of epigenetically silenced genes (Cameron et al., 
1999). 
 
To obtain insights into the altered gene expression program induced by 
TSA and AzaC we performed global gene expression analysis of neuro-
sphere cells treated with TSA, AzaC or TSA plus AzaC (TSA/AzaC). 
Our analysis revealed that TSA/AzaC induced transient expression of 
several stem cell and pluripotency associated genes with a potential im-
pact on the developmental competence of TSA/AzaC treated neuro-
sphere cells (Ruau et al., 2008). 
 
Fig. 3.4.1. AzaC inhibits DNA methylation and TSA inhibits histone 
deacetylation. Adapted from Johnstone et al. 2002 
Upon AzaC/TSA treatment, the chromatin configuration is expected to shift to a more 
open state, making the DNA more accessible to transcription factors. 
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3.4.1 AzaC and TSA Alter Gene Expression in Neuro-
sphere Cells 
NSC from mouse embryonic forebrain form in culture floating colonies 
(Reynolds and Weiss, 1992) referred to as neurospheres. Such neuro-
spheres contain cells that can generate (i) new colonies and (ii) cells that, 
following plating under differentiation conditions, can generate neuronal 
and glial cell types (Schmittwolf et al., 2005). TSA/AzaC treatment of 
neurosphere cells increased the level of histone H4 acetylation and de-
creased methyl-CpG-binding protein (MeCP2) activity (Schmittwolf et 
al., 2005). This is expected to lead to an altered chromatin architecture 
and gene expression pattern (Johnstone, 2002; Clayton et al., 2006). 
Transplantation of TSA/AzaC treated neurosphere cells into irradiated 
recipient mice resulted in a fraction of animals that showed neurosphere 
derived long-term multilineage hematopoietic engraftment (Schmittwolf 
et al., 2005). 
 
To determine the TSA/AzaC induced changes in gene expression, neuro-
sphere cultures were established and treated with AzaC, TSA or 
TSA/AzaC for two days, or left untreated. Neurosphere cells from bcl-2 
transgenic mice and wild type (wt) C57BL/6 mice were used 
(Schmittwolf et al., 2005), RNA was prepared and subjected to microar-
ray analysis. 42-54% of the ~12,000 genes analyzed were found to be ex-
pressed in both untreated and treated cells (Table 3.4.1). Neurospheres 
from bcl-2 transgenic mice were used to protect cells from drug-induced 
apoptosis (Domen et al., 1998; Koyama et al., 2000) and the percentage 
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of expressed genes was lower in bcl-2 neurosphere cells (42.8-47.9%) com-
pared to wt neurosphere cells (51.4-54%). 
 
 
 
Table 3.4.1: Global gene expression of TSA/AzaC treated neurosphere 
cells was assessed by DNA microarray analysis. 
Experiment 
no. 
Treatment % expressed Common List % increased % decreased 
1 Untreated 46.3 - - 
 +AzaC 43.6 2.4 (168) 4.1 (280) 
 +TSA 47.9 11.9 (813) 10.3 (705) 
 +AzaC/TSA 47.1 
54.9% (6815) 
11.1 (759) 9 (618) 
2 Untreated 45.9 - - 
 +AzaC 45 4.9 (332) 6.2 (421) 
 +TSA 42.8 10.5 (702) 16.7 (1118) 
 +AzaC/TSA 47.2 
54% (6709) 
10.6 (713) 15 (1012) 
3 Untreated 51.8 - - 
 +AzaC 52.5 3.1 (229) 3.3 (240) 
 +TSA 54 6.7 (489) 7 (512) 
 +AzaC/TSA 51.4 
58.3% (7248) 
6.8 (496) 10 (724) 
Neurosphere cells of bcl-2 transgenic and wt mice (NSCbcl-2 and NSCwt, Experiment 1 
and 2, and Experiment 3, respectively) were treated with AzaC, TSA or both 
(TSA/AzaC) or left untreated, and subjected to DNA microarray analysis. Data of 
three independent experiments were analyzed and expressed genes are shown in per-
centage of the total number of genes analyzed (12,488, Affymetrix mouse MG_U74Av2 
GeneChip array). Common gene lists contain all genes that are expressed in at least one 
of the samples for each experiment and this gene list was used to calculate the percent-
age of increased and decreased genes. Numbers of genes are given in parentheses. Genes 
with an absolute expression value >60 and expression p-value <0.06 (Present or Mar-
ginal according to Affymetrix classification) were considered as expressed. Genes that 
were up- or down-regulated by more than two fold following TSA/AzaC treatment were 
considered. 
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Surprisingly, AzaC or TSA treatment alone, or the simultaneous treat-
ment with both compounds did not increase the total number of ex-
pressed genes. Drug treatment did however affect gene expression levels, 
involving both increases and decreases in gene expression (Table 3.4.1). In 
TSA or TSA/AzaC treated cells 20.9%±2.1 of the genes analyzed showed 
a change in expression by more than two fold: 9.6%±0.9 of the genes were 
up-regulated while 11.3%±1.5 were down-regulated. AzaC alone did only 
marginally influence gene expression, probably because the microarray 
analysis was done already after 48 hours of treatment, here 3.5%±0.7 of 
the genes were up-regulated and 4.5%±0.9 were down-regulated.  
 
Thus, TSA was more effective than AzaC in inducing changes in gene 
expression and there was no further increase in the number of genes af-
fected by simultaneous treatment with TSA and AzaC. 
 
3.4.1.1 Genome-wide Analysis of TSA/AzaC Induced 
Gene Expression 
To determine whether specific chromosomal regions are particularly sus-
ceptible to TSA/AzaC treatment, we studied the chromosomal distribu-
tion of differentially expressed genes by MACAT BioConductor software 
(Gentleman et al., 2004; Toedling et al., 2004). There was no clear prefer 
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ence of a given chromosome for changes in gene expression induced by 
TSA/AzaC treatment for any of the 21 mouse chromosomes studied 
(Fig. 3.4.2A and data not shown). Additionally, no hotspots of 
TSA/AzaC impact on distinct chromosomal regions were observed. Next, 
 
Fig. 3.4.2. Chromosome analysis by MACAT plot and 3D principal com-
ponent analysis (PCA) of TSA/AzaC treated neurosphere cells 
(A) Gene expression data were analyzed by MACAT software tool (Bioconductor) and 
expression scores of untreated versus TSA/AzaC treated neurosphere cells (red line) are 
plotted along chromosomes 3, 6 and 18. Grey lines indicate the minimum score for differ-
ential gene expression. Dots represent individual genes. An expression score (red line) 
beyond the minimal score (grey lines) indicates a chromosome region where TSA/AzaC 
treatment had a spatially localized effect on gene expression. Chromosome 3 and 18 were 
most prominently affected by TSA/AzaC treatment yet did not exhibit hot spots of gene 
activation. Chromosome 6 is representative for all other chromosomes analyzed but not 
shown. (B) 3D PCA on AzaC, TSA and TSA/AzaC treated neurosphere cells. Every dot 
represents a microarray, which is positioned according to the 3 principal components 
found (PC 1-3), showing a variance of 33.57%, 23.52% and 10.42%, respectively. PC 1 
separates most efficiently untreated and AzaC treated samples from the TSA and 
TSA/AzaC treated samples (right and left circle, respectively). We also noticed that the 
PCA separates bcl-2 neurospheres (experiments 1 and 2, lower data points) and wt neu-
rospheres (experiment 3, upper data points) (PC2 and PC3). 
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gene array data were analyzed by principal component analysis (PCA) 
that clusters data sets according to their degree of correlation (Lefkovits 
et al., 1988). PCA demonstrates that TSA and TSA/AzaC samples clus-
ter together indicating a similarity of the samples at the gene expression 
level (Fig. 3.4.2B). AzaC treated samples cluster with untreated samples 
(PC1). We also noticed that samples from bcl-2 neurospheres cluster to-
gether and are separated from wt neurospheres (PC2). 
 
To further extend the PCA observations, a list of genes was generated 
comprising genes that were more than two fold differently regulated 
upon TSA/AzaC treatment. This gene list was then subjected to hierar-
chical clustering (Eisen et al., 1998) (Fig. 3.4.3). 
 
Given the observation that TSA/AzaC treated neurosphere cells acquired 
long-term hematopoietic potential (Schmittwolf et al., 2005), gene array 
data of purified bone marrow derived Lineage-c-kit+Sca-1+ HSC were 
included in the analysis. Additionally, since TSA/AzaC treatment in-
duced gene expression of early embryonic and pluripotency associated 
genes (see below), undifferentiated ESC were also analyzed. ESC differ-
entiated in vitro into nestin+ cells (Rolletschek et al., 2001) served as a 
further control to allow the identification of genes expressed in ESC but 
not in their differentiated progeny. 
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Hierarchical clustering enabled to clearly distinguish TSA/AzaC induced 
and repressed genes, which were consistently regulated upon treatment 
in both wt and bcl-2 transgenic neurosphere cells (Fig. 3.4.3). Interest-
ingly, some of the TSA/AzaC induced genes were found to be also ex-
 
Fig. 3.4.3. Hierarchical cluster analysis of differentially regulated genes in 
TSA/AzaC treated neurospheres. 
Neurosphere cells were treated with AzaC, TSA and TSA/AzaC or left untreated as in 
Table 3.4.1 and gene array data were subjected to hierarchical cluster analysis. ES cells 
prior to (day 0) and after 11 days of differentiation into nestin+ cells (day 11) and puri-
fied lin-c-kit+Sca-1+ HSC from bone marrow were included in the study. 1358 genes 
were found to be differentially expressed upon treatment. Each gene is depicted by a sin-
gle row of colored boxes. The color of the respective box in one row represents the expres-
sion value of the gene transcript in one sample compared to the median expression level 
of the gene’s transcript for all samples shown. Blue, transcript levels below median; 
white, transcript levels equal to median; red, transcript levels higher than median. 
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pressed in HSC and/or ESC, such as Bex1/Rex3, an early embryonic 
gene expressed already at the 2-cell stage (Williams et al., 2002). ESC 
form a distinct cluster, but share a number of TSA/AzaC induced and 
repressed genes, such as Zfp277/NIRF4, which is found in early embry-
onic stem cells (Liang et al., 2000). 
3.4.1.2 TSA/AzaC Induced HSC and Pluripotency 
Genes in Neurosphere Cells 
Further data mining of TSA/AzaC induced genes identified the HSC 
marker CD34 and several early embryonic and pluripotency-associated 
genes (Oct4, Nanog, Klf4, members of the Dppa gene family). Therefore, 
to assess the kinetics of changes in gene expression, neurosphere cells 
were treated with TSA/AzaC for 6, 12, 24 and 48 hours and RNA was 
subjected to RT-PCR analysis (in collaboration with Roberto Ensenat-
Waser, Institute for Biomedical Engineering, Department of Cell Biology, 
RWTH Aachen). The HSC marker gene CD34, several ESC genes (Oct4 
and Nanog) and pluripotency-associated genes, like Ddx4/Vasa, a known 
early marker of germinal commitment (Tanaka et al., 2000; Toyooka et 
al., 2000; Boiani and Scholer, 2005) were analyzed. Bex1/Rex3 (Williams 
et al., 2002) and the developmental pluripotency-associated (Dppa) genes 
Dppa2, 3, 4 and 5 (Bortvin et al., 2003) were included in this analysis 
(Fig. 3.4.4A). Quantified RT-PCR data were subjected to hierarchical 
clustering and displayed in heatmap format to show patterns of co-
regulated genes (Fig. 3.4.4B). 
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The HSC marker CD34 was progressively induced starting at 24 hours 
and there was also an induction of the stem cell gene CD133. Expression 
of the ESC transcription factors Oct4 and Klf4 were transiently up-
regulated after 24 hours and their expression ceased at 48 hours. 
Bex1/Rex3 and Ddx4 were induced after 12 hours. The pluripotency as-
sociated genes Nanog and the Dppa family members Dppa2, 3, 4 and 5 
were up-regulated after 24-48 hours of TSA/AzaC treatment. At the 
same time we observed a decrease in expression of the neuronal lineage 
 
Figure 3.4.4. Kinetics of HSC and pluripotency associated genes during 
TSA/AzaC treatment of neurosphere cells. 
(A) Total RNA was prepared after various periods of time (0, 6, 12, 24 and 48 hours) 
and analyzed by RT-PCR for the HSC marker CD34, the stem cell associated gene 
CD133, embryonic and pluripotency-associated genes (Oct4, Nanog, Bex1, Ddx4, Klf4 
and Dppa2-5) and neural genes (nestin and β5-tubulin). Loading control, β-actin. (B) 
Kinetics of RT-PCR data for HSC and pluripotency-associated genes during TSA/AzaC 
treatment of neurosphere cells were subjected to hierarchical cluster analysis and are de-
picted in heatmap format to reveal patterns of co-regulated genes. The color of the re-
spective box in one row represents the expression value of the gene transcript in one 
sample compared to the median expression level of the gene’s transcript for all samples 
shown. Blue, transcript levels below median; white, transcript levels equal to median; 
red, transcript levels higher than median. 
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markers, nestin and β5-tubulin (Figs. 3.4.4). Importantly, Dppa3, 4 and 5 
show a biphasic profile with an initial down-regulation followed by an 
up-regulation after 24 hours. Sox2 and c-Myc, two genes implicated in 
pluripotency induction (Takahashi and Yamanaka, 2006; Maherali et al., 
2007; Okita et al., 2007; Wernig et al., 2007), were already abundantly 
expressed in neurosphere cells and their expression remained unaffected 
by TSA/AzaC treatment (Fig. 3.4.5). Additionally, their expression levels 
were similar to those in ES cells. 
 
To directly assess for the potential pluripotent ESC-like phenotype, 
TSA/AzaC treated neurosphere cells were injected under the kidney cap-
sule of recipient mice and teratoma formation was studied (Hogan et al., 
1994). As expected there were no teratomas formed for untreated con-
trols, while injection of ESC yielded massive teratomas after 2-3 weeks 
post-injection (Supp. Fig. 3.4.1; in collaboration with Albrecht Müller, 
Institute for Medical Radiation and Cell Research, University of 
Würzburg, Würzburg, Germany). Mice that developed from blastocysts 
injected with treated neurosphere cells (16 animals) or that were trans-
planted intravenously with TSA/AzaC neurosphere cells (20 animals) 
also did not develop tumors (data not shown). Thus, epigenetic modifi-
cation of neurosphere cells by TSA/AzaC induced the expression of sev-
eral genes associated with stem cell phenotype and/or pluripotency that 
might be involved in enlarging the developmental competence of these 
cells. Furthermore, the TSA/AzaC induced expression of pluripotency 
associated genes was transient and TSA/AzaC treated cells did not de-
velop teratomas. 
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3.4.2 The Potential of Chromatin Modifying Drugs for 
Induction of Pluripotency 
TSA/AzaC induced hematopoietic potential in neurosphere cells 
(Schmittwolf et al., 2005) and we hypothesized that treatment causes a 
reprogramming of cells towards (i) a hematopoietic fate or (ii) a pluripo-
 
Figure 3.4.5. Boxplot graphs of 
Sox2, c-Myc and Klf4 gene ex-
pression in TSA/AzaC treated 
neurosphere cells. 
Expression of Sox2, c-Myc and Klf4 
were analysed by microarray in un-
treated, AzaC, TSA and TSA/AzaC 
treated neurosphere cells. Expression 
levels were quantified and compared to 
those measured in undifferentiated ES 
cells, ESC-derived nestin+ precursors 
and HSC. 
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tent program and from there cells get committed into the hematopoietic 
lineage. To investigate this hypothesis TSA/AzaC treated neurosphere 
cells, and as controls hematopoietic stem cells and ES cells, were sub-
jected to gene expression profiling by DNA microarray analysis. We show 
that TSA/AzaC treatment induced in neurosphere cells the expression of 
several genes associated with stem cell phenotype and pluripotency that 
might be responsible for or contribute to enlarge the developmental com-
petence of these cells. TSA/AzaC induced genes included (i) the HSC 
marker gene CD34, (ii) pluripotency associated genes, such as Oct4, 
Nanog, Klf4, Dppa2, 3, 4 and 5, and (iii) the early embryonic gene 
Bex1/Rex3. 
 
TSA/AzaC treatment did not increase the percentage of expressed genes 
in neurosphere cells and did not show any preference for a particular ge-
nomic region or chromosome, but did significantly alter the repertoire of 
expressed genes. As cell identity is determined by the expression of a de-
fined set of genes, changes in gene expression are expected to lead to 
changes in cell phenotype and function. TSA/AzaC induced the HSC 
gene CD34 and the stem cell gene CD133, which is also expressed in 
HSC, suggesting that neurosphere cells can adopt features of HSC. 
Thereby, such cells might acquire a level of competence which, following 
transplantation and homing in the bone marrow, generates sustained 
and transplantable hematopoietic activity (Schmittwolf et al., 2005). 
 
Recently Yamanaka and colleague (Takahashi and Yamanaka, 2006; 
Okita et al., 2007) and two further studies (Maherali et al., 2007; Wernig 
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et al., 2007) identified four reprogramming genes (Oct4, Sox2, c-Myc and 
Klf4) that by retroviral transfer induced an ESC-like state in fibroblasts 
referred to as iPS cells. Interestingly TSA/AzaC induced Oct4 and Klf4, 
while Sox2 and c-Myc were not induced but expressed constitutively. 
Thus, it is tempting to speculate that this combination of factors in-
duced an ES cell-like state in neurosphere cells, similar to what is ob-
served in fibroblasts (Takahashi and Yamanaka, 2006; Maherali et al., 
2007; Okita et al., 2007; Wernig et al., 2007). Therefore, TSA/AzaC in-
duced activation of pluripotency associated genes, such as Oct4, Nanog 
and Klf4, together with constitutively expressed Sox2 and c-Myc, might 
generate a state of competence that following adoptive transfer into ani-
mals and integration in the HSC niche causes commitment to HSC. 
TSA/AzaC treated neurosphere cells did not generate teratomas, indicat-
ing that they did not acquire full ESC activities. This might be because 
the induction of pluripotency-associated genes is transient and with the 
experimental conditions employed does not result in a stable ESC state. 
 
TSA/AzaC treated cells expressed further pluripotency-associated genes 
in addition to Oct4, Klf4, Sox2 and c-Myc, and these might very well be 
involved in or even be required for reprogramming of neurosphere cells. 
These genes included several members of the Dppa family, such as 
Dppa2, Dppa4 and Dppa5, and the germ line genes Ddx4/vasa/Mvh and 
Dppa3/Stella. Dppa genes exhibit an expression pattern similar to Oct4 
(Bortvin et al., 2003) and might be specifically involved in induction 
and/or maintenance of pluripotency in stem cells. We hypothesize that 
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these genes might be part of the cellular machinery required for the com-
pletion of the reprogramming events observed. 
 
Concomitantly with the induction of pluripotency-associated genes neu-
ronal lineage genes, such as nestin and β5-tubulin were down-regulated. 
This might be because expression of pluripotency associated genes and 
lineage marker genes are mutually exclusive. On the other hand, c-Myc 
and Sox2 were abundantly expressed in both neurosphere cells and ESC, 
and there was no further up-regulation by TSA/AzaC treatment, yet 
they might be important players in the reprogramming event, apparently 
in concert with other factors. 
 
The reprogramming system by TSA/AzaC relies on the activation of en-
dogenous genes by employing defined chemical compounds and transient 
destabilization of the epigenotype of somatic precursor cells. TSA/AzaC 
treatment of human CD34+ cells from bone marrow was found to in-
crease the frequency of SCID mice repopulating cells (Milhem et al., 
2004). This demonstrates the potential application of such strategies for 
enlarging the developmental capacity of human somatic stem cells and 
their use in medical therapy. 
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3.5 Pluripotent Stem Cells Induced from Adult 
Neural Stem Cells by Reprogramming with Two 
Factors 
 
 
We showed that NSC express high levels of reprogramming factors Sox2 
and c-Myc similar to ES cells (Fig. 3.4.5). Thus, 2F iPS cells were gener-
ated by exogenous expression of Oct4 and Klf4 or Oct4 and c-Myc. 2F 
iPS cells are similar to ESC at the molecular level, contribute to develop-
ment of the germline and form chimeras (Kim et al., 2008). Here, we in-
vestigate the expression profile between iPS cells generated using only 
two factors (2F iPS cells), original NSC before reprogramming, four fac-
tors iPS cells from NSC and from MEF. 
 
First, we investigated different iPS cells for their global gene expression 
profile by hierarchical clustering. The expression values were compared 
using the cosine distance and the average linkage method was used to 
build the agglomerative hierarchical tree. 2F iPS cells cluster close to ESC 
and 4F iPS (Fig. 3.5.1). Interestingly, 2F iPS cells exhibited a greater cor-
relation to ESC than four-factor iPS cells generated from MEF or NSC.  
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In a second step, we looked at the genes differently expressed between 2F 
iPS and NSC as well as between 2F iPS cells and ESC. Scatter plot and 
volcano plot of DNA microarray expression values demonstrated a higher 
similarity between 2F iPS cells and ESC (Fig. 3.5.2A and B) than be-
tween NSC and ESC (Fig. 3.5.2C and D). However, 2F iPS cells are not 
completely identical to ESC. Genes like Id4, implicated in the inhibition of 
oligodendrocyte development, was express at level eight times greater in 
ESC than in 2F iPS cells (Samanta and Kessler, 2004). Thus, 2F iPS 
cells seemed to be very similar to mouse ESC at the global transcription 
level but some neuronal lineage gene from the original NSC are not com-
pletely turned off by reprogramming. For Id4 this could be interpreted as 
residual somatic memory. 
 
Fig. 3.5.1. Global expression profile hierarchical clustering of different iPS 
cells 
Global gene expression profile was subjected to hierarchical clustering using average 
linkage method. NSC: Neural stem cells; 4F NSC and 4F MEF: four-factor repro-
grammed cells either from NSC or mouse embryonic fibroblast (MEF). 2F NSC are re-
programmed NSC with two factors. ESC: Embryonic stem cells. 
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3.5.1 Pluripotency and Neuronal Differentiation Regu-
latory Network 
To further investigate the reprogramming obtained by two factors (Oct4 
and Klf4), a regulatory network of pluripotency genes was generated 
based on curated literature source and experimental results found using 
 
Fig. 3.5.2. Scatter and volcano plot of global gene expression profile for 
ESC, 2F iPS cells and NSC. 
(A) Scatter plot of normalized expression value of 2F iPS cells against ESC. (B) Volcano 
plot representing the gene expression fold change between 2F iPS cells and ESC on the x 
axis and the p-score (reliability of the measure) on the y axis. (C) Scatter plot and (D) 
Volcano plot between NSC and ESC. 
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iHOP (www.ihop-net.org) and STRING (http://string.embl.de/) online 
databases (Hoffmann and Valencia, 2004; Jensen et al., 2009) (Fig. 3.5.3). 
This network was represented using the Cytoscape software 
(www.cytoscape.org) and gene expression intensities were displayed over 
the network using the dynamicXpr plugin (Cline et al., 2007). 
 
The reprogramming factors Oct4 and Klf4 both inhibit in an indirect 
way the neuronal lineage differentiation. Oct4 through Cdx2 regulates 
Smad3 expression (Calon et al., 2007; Chickarmane and Peterson, 2008). 
Klf4 prevents the activation of Smad3 and the formation of the 
STAT3/Smad1/p300 complex by antagonistic competition binding to 
p300 (Yanagisawa et al., 2001; Feinberg et al., 2005; Hu et al., 2007). In-
terestingly, Cdx2 expression level was undetectable in neither ESC, 2F 
iPS cells nor NSC, suggesting a key regulatory effect of Klf4 for repres-
sion of the astrocyte generation or other regulatory mechanisms triggered 
by Oct4. The leukemia inhibitory factor (LIF) is a cytokine necessary for 
maintaining the undifferentiated state of cultured mouse ESC and 2F 
iPS cells. Here, LIF plays a dual role in promoting the astrocyte genera-
tion and maintaining pluripotency by inducing c-Myc expression via acti-
vation of STAT3 (Okita and Yamanaka, 2006). At the present stage of 
knowledge, the reprogramming factor c-Myc is difficult to position. The 
high level of expression of Id4 observed can explain the neuronal lineage 
repression in 2F iPS cells. Id4 physically interact with Olig1/Olig2/E2A 
complex and is suggested to account for glial lineage commitment block-
age (Samanta and Kessler, 2004). 
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Fig. 3.5.3. Pluripotency regulatory network 
Schematic representation of reprogramming factors Oct4, Klf4, Sox2 and Nanog in a 
regulatory gene network of pluripotency and neuronal differentiation (bottom and top, 
respectively). The nodes represent genes and are colored according to their expression 
levels. White for undetected and red for highly express. Blue indicates Oct4-Sox2 com-
plex. 
????
????
????
NSC
2F iPS
ESC
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In conclusion, Oct4 together with either Klf4 or c-Myc can reprogram 
NSC into pluripotent stem cells (in collaboration with Jeong Beom Kim 
et al., Department of Cell and Developmental Biology, MPI for Molecular 
Biomedicine, Münster, Germany). We propose that endogenous expres-
sion of Sox2 plus exogenous expression of two factors, including Oct4, is 
sufficient to induce the generation of iPS cells from adult NSC. However, 
it is not clear why exogenous expression of either Klf4 or c-Myc is still re-
quired for reprogramming, because these genes are endogenously ex-
pressed in NSC. 
 
Human NSC might be available from patient biopsy (Nunes et al., 2003), 
and it will be particularly interesting to assess whether they can be re-
programmed with the currently described two-factor method. The clinical 
applicability of cellular reprogramming is incumbent on the optimization 
of the approaches that obviate problems caused by retroviral insertional 
mutagenesis. Chromatin-modifying agents, such as TSA and AzaC, in-
duce the transient expression of several pluripotentcy-associated genes, 
including Oct4 and Klf4 (Ruau et al., 2008). This indicates that such 
chemical compounds could replace one or more reprogramming factor(s) 
and, in this regard, the two-factor transcription factor reprogramming 
induction model holds great potential.
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3.6 Optimized Semantic Annotation Workflow 
for Public Microarray Repositories 
 
 
To harness the amount of information stored in public microarray re-
positories, such as Gene Expression Omnibus (GEO) (Barrett et al., 
2005), Array Express (AE) (Parkinson et al., 2007) and Stanford Mi-
croarray Database (SMD) (Demeter et al., 2007), intelligent and specific 
search tools need to be developed. Microarray experiments are required to 
be publicly available by most journals through the main databases. GEO 
with more than 250,000 microarray experiments in the public domain 
acts like a tantalizing source of information, which is completely 
underused. For the moment, only a few studies relate public genomic ex-
periments to other sources of knowledge. Butte and Chen (Butte and 
Chen, 2006) linked disease terms from PubMed abstracts to GEO ex-
periments, thereby relating 270 human diseases to their global expression 
profile. However, not all microarray experiments in GEO are documented 
with a PubMed accession number. Despite that the Minimum Informa-
tion About Microarray Experiments (MIAME) (Brazma et al., 2001) re-
quirements are implemented in the public databases, the authors have to 
use free text to describe their experiments. The MIAME format do not 
impose the usage of biomedical ontology that are increasingly used to an-
notate biological experiment (Rubin et al., 2008). Hence, the descriptions 
entered makes the retrieval of experiments sensitive to spelling variants 
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introduced by the submitter. Consequently, text mining received major 
attention as a solution to automatically organize and mine microarray 
experiments using all the information available from the databases 
 
3.6.1 Related Work 
GEO uses different granularities to organize its data. The highest level is 
the GEO Data Sets (GDS) that are curated versions of the GEO Series 
(GSE). The GSE are defined by the submitter as a batch of microarray 
samples (GSM) belonging to the same experiment. Currently, to search 
GEO, users can either use (i) the web interface provided by the GEO 
web portal, (ii) BioPortal a powerful approach linking ontology term to 
microarray experiments (Rubin et al., 2006) or (iii) GEOmetadb, which is 
the GEO database containing only the description of the information 
about the data sets but not the raw data (Zhu et al., 2008). However, 
both GEO web portal and GEOmetadb do not perform an extension of 
the query for semantic synonyms. Furthermore, GEO and BioPortal do 
not allow the retrieval of GSM directly but only GDS or GSE series, the 
upper organization levels. GDS and GSE descriptions are often too broad 
and a better quality of annotation can be achieved if the GSM are con-
sidered directly. Other approaches annotated GEO using the Unified 
Medical Language System (UMLS) (Bodenreider, 2004; Butte and 
Kohane, 2006). UMLS is a combination of ontologies but does not incor-
porate cell descriptions. Thus, information about cell and cell line tested 
with the microarray could not be mined. 
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In this study the aim was to produce an accurate semantic annotation 
method for microarray experiments stored in public repositories, enabling 
easy retrieval of relevant single microarray experiments by searching for a 
cell type/tissue/disease by its abbreviation or one of its spelling variants. 
For this purpose, a general workflow was developed that relies on two 
types of information available in microarray databases: the text descrip-
tions and the numerical raw data. The raw data represent the gene ex-
pression value measured by the microarray from the biological material. 
While the workflow can be applied to any of the microarray databases 
following the MIAME requirements, we focused on GEO as a proof of 
concept. This work demonstrates the feasibility of obtaining highly accu-
rate semantic annotation by combining text- and data mining techniques. 
 
3.6.2 Semantic Annotation Workflow 
The workflow (Fig. 3.6.1) shows different sources of knowledge used to 
annotate GEO entries. It can be separated in three mining steps. In the 
first step, text mining is performed with ProMiner (Hanisch et al., 2005) 
and associate one or more class label(s) to the data (Fig. 3.6.1A). How-
ever, as text mining relies on the free text descriptions from GEO two 
problems occur, (i) objects with unclear description do not receive a class 
label and (ii) the attributed class label(s) can be wrong. To overcome the  
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text mining limitations, two data mining techniques were used sequen-
tially in the workflow. First, the semantic outlier factor (SOF) was run 
to identify erroneously labeled objects (second step in the workflow; Fig. 
3.6.1B) (He et al., 2002). The SOF value enabled us to improve the text 
mining step by discovering objects showing a discrepancy between their 
expression value profile and their class label. Second, an adapted label 
 
Fig. 3.6.1. Annotation workflow for public microarray repository. 
Cell type, mouse gross anatomy and human disease ontologies as well as web resources 
for cell lines were used to annotate the microarray experiments. (A) The text mining 
software ProMiner associates class labels to the samples from public microarray reposito-
ries. In parallel, the available raw data are processed and (B) used in conjunction with 
the class labeling results to discover the text mining errors. (C) Labels are propagated 
from labeled samples to closely related unlabeled sample(s). Results are stored in the 
GEOannot relational database. 
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propagation technique was developed following the k-nearest neighbour 
approach, improving the annotation coverage percentage without increas-
ing the error rate (third step; Fig. 3.6.1C). The complete annotation and 
ontology resources are stored in a relational database, GEOannot. The 
relational database can easily be queried from BioConductor using the 
RSQLite package (Gentleman et al., 2004; James, 2008) or interfaced 
with a web portal. 
3.6.2.1 Linking Microarray Experiments to Knowledge 
In the present study the named entity recognition was performed with 
ProMiner (Hanisch et al., 2005), a software originally developed to iden-
tify gene and protein names in biomedical text. The name entity detec-
tion of ProMiner is based on an approximate search algorithm that uses 
synonym lists, also called dictionaries. A dictionary was build based on 
cell, tissue and disease ontologies from the OBO foundry (Smith et al., 
2007) plus cell line descriptions. Cell line experiments represent a non-
negligible number of samples in GEO and thus information based on Hy-
perCLDB  and the German collection of microorganism and cell line 
(DSMZ)  web resources completed the dictionary. The resulting diction-
ary comprises 1,776 entries for cells and cell lines, 2,775 for tissue types 
and 14,727 for diseases. 
 
The GSM level of description was annotated by mining the description 
entered by the submitter in the title, the source or the description field. 
This resulted in 63.5-97.6% class labeling of the GSM objects (Supple-
mentary Table 3.6.1). Nineteen microarray platforms were annotated by 
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text mining, but only five were subjected to the totality of the workflow 
for processing and storage reasons. Human related microarray samples 
showed a lower coverage percentage (63.5% for platform hgu133plus2). 
Reviewing the unlabeled objects revealed more anonymously labeled ex-
periments coming from biological material of patients and a very broad 
spectrum of cell lines that were not present in our dictionary. This mis-
performance will disappear, as the dictionary will improve. 
3.6.2.2 Detecting Outlier in Text Mining Results 
Following the first text mining annotation step, two sets of GSM objects 
are obtained. One set assigned with one or more class labels and another 
one without labels. We define them formally in Definition 1. 
Definition 1 Let CL = {cl1,…,clm} be the set of class labels describing 
the objects (microarray experiments) contained in the database D = 
{t1,…tn}. The set of labeled objects is denoted as A: t ∈ D|cl and the set 
of unlabeled objects B:t ∈ D|t ∉ A such that A ∩ B=0 and A ∪ B=D. 
For a subset of the objects in category A their numerical raw data are 
available and the outlier detection method is applied only to them. The 
raw data given by the microarray represent a quantification of the gene 
expression of the entire genome at a particular time point. The expres-
sion value can be pre-processed, normalized and subjected to different 
data mining methods. Logically it is expected that similar microarray ex-
periment objects cluster together and thus should have identical class la-
bel(s). 
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Outlier detection is an important field with broad applications such as 
fraud detection in financial transactions or even spam filtering. Outlier 
detection focuses on the objects that cannot be assigned to any group. 
Current methods like OutRank, a method for ranking outlier in high di-
mensional data using subspace clustering (Müller et al., 2008), or LOF, 
(Breunig et al., 2000) perform a ranking of the outlier found and associ-
ate a degree of “outlierness” to every object. However, the last generation 
of arrays can measure 45,000 genes in a single experiment and the data 
set size can reach hundreds of samples. Approaches like OutRank and 
LOF do not scale well for such large data sets. LOF and OutRank can 
only handle a maximum of 5 and 50 dimensions, respectively. Methods 
like the Fowlkes-Mallows index (Fowlkes and Mallows, 1983), the Rand 
index (Rand, 1971) or the F-measure by van Rijsbergen (van Rijsbergen, 
1990) for measuring the quality of the classification proposed by 
ProMiner give a global value, which is not useful to determine if a par-
ticular object is an outlier in its class. 
 
The SOF method rely on a statistic measure to discover the semantic 
outliers (He et al., 2002). In brief, SOF partitions the database in k clus-
ters and calculates three parameters for every object t: (i) the frequency 
of the class label cli within the cluster Ck, Pr(cli|Ck), (ii) within the data-
base D, Pr(cli|D) and (iii) the similarity between the object t and all the 
other objects in the same class, sim(t,R). The SOF value is then calcu-
lated as follows (1):  
€ 
SOF(t) = Pr(cli |Ck ) × sim(t,R)Pr(cli |D)
           (1) 
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The true number of class labels in the database is unknown. For the 
partitioning of the database we estimated k as the actual number of class 
label |CL| discovered in the data by the text mining software. The out-
liers are defined as the objects with greater value of SOF than the rest of 
the objects in the same class. Fig. 3.6.2A shows the SOF value for the 
objects annotated “testis” belonging to the mouse microarray measured 
on platform mgu74av2. The microarray samples GSM12790 and 
GSM9913 are both from the same submitter and described in the same 
way as “testis tubular somatic cells”, but received incorrectly the label 
“testis”. The term “testis tubular somatic cells” was not present in the cell 
type ontology and has now been added to the dictionary.  
 
As a general observation, text mining errors tend to be repeated across 
entire series (GSE) submitted by the same user, as the descriptive text is 
often identical (copy-paste). The class “blood” exemplifies this specific 
type of error (Fig. 3.6.2B). Here the objects above the threshold (blue 
line) are our previously submitted data (Ruau et al., 2006) from hema-
topoietic stem cell and the objects below are T cells (Lund et al., 2003). 
When a discrepancy is found using the SOF value, it is necessary to ex-
plore both groups of outliers. The outliers are detected and stored for 
future analysis in order to improve the next round of annotation. Run-
ning the semantic outlier detection method allowed to increase the accu-
racy of the class labeling by improving the dictionary. Numerous syno-
nyms were added to existing terms especially in the cell type ontology. 
We also created specific entries for samples, such as “mammary epithelial 
stem cell”, which recently received major attention (Stingl et al., 2006). 
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3.6.2.3 knnDelta: Class Label Propagation 
In the next step, the labeled objects were used to annotate similar unla-
beled objects from the subset B (Definition 1). As the true number of 
class labels is unknown, the database should not obligatorily be com-
pletely annotated. We followed the k-nearest neighbour approach to im-
plement a novel algorithm that propagates annotations with a limiting δ 
range parameter. 
 
The knnDelta algorithm starts from the correlation matrix of all objects, 
unlabeled or labeled, where the raw data are available. Then for every 
class label, the average distance between all points of the class is calcu-
lated. This value is called the δ range. The δ range of a class gives an in-
dication of its compactness (Fig. 3.6.3). KnnDelta iterates over all classes 
 
Fig. 3.6.2. Example of semantic outlier results for two class label groups. 
Semantic outlier factor plot for labeled microarray object labeled (A) testis and (B) 
blood. The blue line represents the mean plus two times the standard deviation of the 
SOF values for the class considered. 
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and every labeled object t. The algorithm propagates the class label of t 
to all unlabeled object within its δ range. The propagation starts with 
the class having the smallest δ range to solve the problem of overlapping 
δ range (objects b and c; Fig. 3.6.3). When the cardinality of the class 
was too small, an empirically pre-determined δ range value was used. 
This allowed us to propagate annotations only between related microar-
ray experiments. We observed an increase in the annotation coverage by 
up to 9.4% with an accuracy of 79.5% for the human hgu95av2 platform 
(Suppl. Table 3.6.1). The class labeling overall percentage after annota-
tion propagation reached 82.9-99.1% (Suppl. Table 3.6.1). 
 
Figure 3.6.3. Label propagation using knnDelta 
Synthetic data set for hypothetical microarrays measuring two genes. The unlabeled mi-
croarray experiments are denoted by ‘x’. Dotted circles indicate specific δ range for the 
different classes. The unlabeled object between class ‘b’ and class ‘c’ situated in overlap-
ping δ range will receive label ‘c’. 
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3.6.2.4 GEOannot Database 
The annotations assigned by text mining, corrected by the semantic out-
lier factor and propagated based on a semi-supervised clustering ap-
proach were stored in a relational database. A relational model integrat-
ing the GEO information, as well as the ontologies used was imple-
mented. Thus, the GSM and associated GSE are linked to one or more 
ontology node. The database makes it possible to drill up or down to the 
parent(s) or the children of a node. This navigation feature enables a 
comprehensive browsing of the microarray experiments. 
 
3.6.3 Evaluation of GEOannot 
The search results of our database were evaluated against the standard 
GEO web interface for the same queries. Two terms were searched: “hsc” 
to find hematopoietic stem cell samples and “keratinocyte” (Fig. 3.6.4). 
Searching GEOannot for “hsc” retrieved 20 GSE identifiers against 25 us-
ing the online search function from GEO (Fig. 3.6.4A). 
The GSE returned by GEOannot are all true positive. The searches over-
lap on 14 GSE indicating that 6 GSE were only found when the “hsc” 
term is extended to its semantic synonyms in GEOannot. Among the 11 
GSE only returned by the GEO web interface, 5 were false positives. 
When querying for “keratinocyte”, the GEO web interface retrieved 20 
additional GSE than GEOannot (Fig. 3.6.4B) but again a considerable 
fraction of them were false positive (75%). The word “keratinocyte” 
matched in some growth protocol conditions describing “keratinocyte se-
rum-free medium”. Thus, the searches using GEOannot are more accu-
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rate and reliable than the GEO online query interface. In addition, the 
results provide the relevant GSM ID directly and suppress the task of 
sorting out which samples are relevant in the series. However, some in-
formation are stored only at the GSE level and not repeated in the GSM 
descriptions. We are currently working on the integration of some GSE 
text fields into the annotation workflow only for the objects that did not 
receive a class label after the first text mining step. 
 
 
Fig. 3.6.4. Search accuracy comparison between GEOannot and GEO web 
interface 
The number of GSE found were compared using either our database GEOannot (blue) 
or the online web interface of GEO (red). (A) Search for abbreviation “hsc” standing for 
hematopoietic stem cell. (B) Search results for “keratinocyte”. 
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3.6.4 GEOannot for Integrative Genomics 
Lately, integrative genomic studies using already published experiments 
have received major attention from the community (English and Butte, 
2007) and new search tools have began to appear. GEOmetadb, for ex-
ample, allows a more powerful search of the existing description in GEO 
than the web interface (Zhu et al., 2008). However, GEOmetadb is a tool 
specific for GEO and does not allow semantic search or ontology brows-
ing. The solution proposed in the workflow can be applied to every mi-
croarray repository to build a semantically queriable database. The heart 
of the method relies on two data mining techniques: one for outlier detec-
tion and one for label propagation. The SOF value depends on the input 
parameter k for partitioning the database, where |CL| was found to be a 
good approximation. The label propagation knnDelta algorithm is highly 
influenced by the number of classes discovered by the text mining. If the 
available raw data are too few, the number of classes diminishes and the 
label propagation becomes ineffective. This problem will tend to disap-
pear, because the number of microarrays increases over time as well as 
the annotation quality. For the legacy array types, where no new data 
sets are submitted, a solution would be to apply the propagation algo-
rithm to different microarray platforms at the same time. This would re-
sult in a data set with increased number of class labels available to 
propagate to unlabeled objects. For this, the problems of pre-processing 
and comparison between different arrays have to be overcome. Many re-
search projects would benefit from re-using publicly available experi-
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ments, for instance to increase the statistical significance of genes found 
to be regulated by introducing more control samples in the analysis. 
 
In summary, the workflow developed in this work takes advantage of text 
mining and data mining solutions to obtain highly accurate annotation 
of objects stored in public microarray repositories. Biomedical ontologies 
were used as source of annotations with the objective of being able to 
search for objects by their known synonyms and to browse the ontology 
to find related samples. The novel knnDelta algorithm increases the an-
notation coverage in an adapted fashion for microarray data. Thus, the 
approach presented here revealed its potential when searching for disease 
related experiments where spelling variants and abbreviations are numer-
ous. The annotation workflow will be automated in order to release the 
database GEOannot on a regular basis in the near future. GEOannot will 
provide a good alternative to the online query interface from GEO where 
the user can obtain pre-annotated microarray samples avoiding the tedi-
ous labeling phase before analyzing. 
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4 Conclusion and Perspectives 
 
 
4.1 Conclusion 
DNA microarray technology allows unprecedented level of understanding 
of the cell system by measuring almost all known genes of an organism at 
once. Expression arrays can be used in numerous experimental designs 
ranging from time course, drug dose response to disease stage analysis. 
The DNA microarray platform can, not only measure gene expression, 
but also protein-DNA binding as well as detecting single nucleotide po-
lymorphisms (SNPs) over the entire genome. The huge amount of infor-
mation generated for a wide variety of biological material is constantly 
growing, making online repository databases exceptionally rich for inte-
grative genomics studies. 
 
In this work, the DNA microarray technology was reviewed by giving an 
overview of the challenges in the pre-processing steps and of the existing 
supervised and un-supervised clustering solution available to the commu-
nity. Several hierarchical clustering techniques and the classical metrics 
used to mine microarray data were presented (This work was adapted 
from published work (Ruau and Zenke, 2008). In the second part, the 
results of gene expression profiling applied to dendritic cells (DC) treated 
with TGF-β1 are presented. TGF-β1 induces maturation of DC and is a 
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process occurring in nature. We show that TGF-β1 has a strong and fast 
gene regulatory effect on DC. Genes regulated belong to the immune re-
sponse and defense against pathogen functional category. In our system 
DC regulated different groups of genes according to the time of treat-
ment indicating a unique processing of the signal by the cell. 147 tran-
scription factor including Id2, Runx3 and IRF8 were found up-regulated 
by TGF-β1 treatment through the Smad signaling pathway (this work is 
the synthesis of three publications (Ruau et al., 2006; Ju et al., 2007; 
Ruau and Zenke, 2008). 
 
The third part focuses on the stem cell genomics and reprogramming of 
somatic cells to make them acquire novel properties, a process that does 
not normally occur in nature. The different techniques in the field to ob-
tain pluripotent stem cells from somatic cells are reviewed. In a recent 
study we demonstrated that NSC could be reprogrammed by two epige-
netic modifying drugs AzaC and TSA. Treated NSC re-activated key 
genes involve in pluripotency. Somatic cells can also be reprogrammed 
into iPS cells by transfecting somatic cells with four exogenous factors 
(Oct4, Klf4, Sox2, and c-Myc). Only two factors (Oct4 and Klf4) are nec-
essary to transform NSC into iPS cells. Chapter 3.5 presents a gene ex-
pression analysis performed on those new iPS cells and shows that 2F 
iPS cells are really close to ESC in expression profile (This part was pub-
lished partially in (Kim et al., 2008). A regulatory gene network of pluri-
potency and neuronal differentiation was used to display the variation in 
gene expression levels. The network gives insight on the pluripotency-
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associated genes interaction and suggests that 2F iPS cells retain residual 
somatic memory. 
 
In the last chapter of this thesis, a semantic annotation workflow for 
public microarray repositories is presented. The continuously growing 
number of microarray experiments available through Gene Expression 
Omnibus (GEO), ArrayExpress (AE) or Stanford Microarray Database 
(SMD) represents an enormous amount of data completely underused. 
The new method proposed in this thesis has three major steps, first a 
text mining software annotates microarrays with ontologies terms. Then 
a semantic outlier detection method is applied to detect wrongly labeled 
objects. Based on this reliably annotated database, a label propagation 
technique was developed using the k-nearest neighbor approach. The an-
notations generated by the workflow allow more accurate retrieval of ex-
periments than the online search engine (This work is in revision by 
BMC Bioinformatics). 
 
4.2 Perspectives 
Genome-wide events occurring in nature like DC respond to TGF-β1 and 
artificially induced by reprogramming factors in somatic cells and adult 
stem cells can be studied using DNA microarrays. Monitoring the entire 
genome of a system allows unprecedented level of understanding. How-
ever, the current biology’s challenge is to translate the information gained 
over the system into knowledge.  
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One of the major interests of the biomedical community is to find cures 
to diseases. In this respect, iPS cells hold a great potential for regenera-
tive medicine as well as for our understanding of the disease itself 
through the generation of patient specific stem cells. Because of their self-
renewal capacity disease-model stem cells would allow for example the 
study of early events of the development of a particular disease. 
 
The TGF-β1 signaling pathway has been very well studied in adult stem 
cells and a particular interest rose recently regarding its role in cancer 
stem cells biology. Cancer stem cells exhibit properties from stem cells 
and can be isolated and studied. TGF-β1 has been found to be impli-
cated into epithelial-mesenchymal transition (EMT) observed during me-
tastasis of tumor (Watabe and Miyazono, 2009). TGF-β1 signals through 
Smads and has different effects according to the type of cells considered. 
However, Smads molecules are also regulated by pluripotency factors like 
Oct4, Klf4, Sox2, c-Myc and Nanog. Thus, it would be of particular in-
terest to investigate the potential of drugs directed against TGF-β1 
downstream target to increase the reprogramming rate of the somatic 
cells subject to reprogramming. With the recent observation that NSC 
can be reprogrammed into iPS cells only by Oct4 or without additional 
reprogramming factor or viral integration (Okita et al., 2007; Okita et al., 
2008; Kim et al., 2009) 
 
Translational bioinformatics focus on merging different types of informa-
tion such as gene expression value with patient disease state. Being able 
to re-use publicly available data sets to answer questions, where the data 
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set size is a key factor is of major importance for research. However, the 
next bottleneck in this research type could be the availability of accurate 
descriptions for public data sets. For this reason, linking microarray ex-
periments to ontology terms allows to define precisely the nature of the 
biological material tested. The next challenges in semantic annotation of 
microarray experiments would be to integrate drug ontologies into the 
dictionary of ProMiner. Allowing the retrieval of disease treatment mi-
croarray experiments. This would represent a major step forward for in-
tegrative genomic studies. 
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Supplementary Figure 3.4.1. Analysis of teratoma potential of 
TSA/AzaC treated neurosphere cells. 
105 ES cells or 105 TSA/AzaC treated neurosphere cells were injected under the kidney 
capsule of SCID recipient mice. Animals were analyzed for teratoma formation 4 weeks 
post injection with ES cells (A) and 6-8 weeks post injection in animals receiving 
TSA/AzaC treated neurosphere cells (C). There were no teratomas formed by TSA/AzaC 
neurosphere cells (C). Histological sections of teratomas from (A) are shown in (B). 
Right panel, kidney control. Cartilage, Ca; Secretory gland, Gla; Muscle, Mu; Glomeru-
lus, Glo. (in collaboration with Albrecht Müller, Institute for Medical Radiation and 
Cell Research, University of Würzburg, Würzburg, Germany) 
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Supplementary Table 3.6.1. GSM object annotation coverage 
Microarray description (GEO platform 
code) 
Annotation coverage 
mouse4302 (GPL1261) 87.2% 
mouse430a2 (GPL339) 91.1% 
mouse430b (GPL340) 97.6% 
hgu133plus2 (GPL570) 63.5% 
hgu133a2 (GPL571) 74.3% 
hu6800 (GPL80) 69.1% 
mgu74av2 (GPL81) 86.2% 
mgu74bv2 (GPL82) 87.4% 
mgu74cv2 (GPL83) 94.1% 
mgu74a (GPL32) 96% 
mgu74b (GPL33) 90% 
mgu74c (GPL34) (*) 100% 
hgu95a (GPL91) 73.5% 
hgu95b (GPL92) 73.2% 
hgu95c (GPL93) 73.4% 
hgu95d (GPL94) 85.2% 
hgu95e (GPL95) 85.2% 
hgu133a (GPL96) 69% 
hgu133b (GPL97) 70% 
Annotation coverage of the 19 selected microarray platforms after the first text mining 
step of the workflow. (*) Only 9 samples were present for this platform. 
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